<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Aging Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-4365</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">32317956</article-id><article-id pub-id-type="pmc">7019015</article-id><?properties open_access?>
<article-id pub-id-type="doi">10.3389/fnagi.2020.00026</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Microbial BMAA and the Pathway for Parkinson’s Disease
                    Neurodegeneration</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nunes-Costa</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/897563/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Magalhães</surname>
<given-names>João Duarte</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/814860/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>G-Fernandes</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cardoso</surname>
<given-names>Sandra Morais</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/156336/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Empadinhas</surname>
<given-names>Nuno</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/196399/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>CNC–Center for Neuroscience and Cell
                    Biology, University of Coimbra</institution>, <addr-line>Coimbra</addr-line>,
                    <country>Portugal</country></aff>
<aff id="aff2"><sup>2</sup><institution>Ph.D. Programme in Biomedicine and Experimental
                    Biology (PDBEB), Institute for Interdisciplinary Research, University of
                    Coimbra</institution>, <addr-line>Coimbra</addr-line>,
                    <country>Portugal</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute of Cellular and Molecular Biology,
                    Faculty of Medicine, University of Coimbra</institution>,
                    <addr-line>Coimbra</addr-line>, <country>Portugal</country></aff>
<aff id="aff4"><sup>4</sup><institution>Institute for Interdisciplinary Research
                    (IIIUC), University of Coimbra</institution>, <addr-line>Coimbra</addr-line>,
                    <country>Portugal</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Nicola Simola, University of Cagliari, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Steven Robert Brenner, Saint Louis University, United States;
                        Agata Copani, University of Catania, Italy</p>
</fn>
<corresp id="c001">*Correspondence: Sandra Morais Cardoso
                        <email>cardoso.sandra.m@gmail.com</email> Nuno Empadinhas
                        <email>numenius@cnc.uc.pt</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>12</volume>
<elocation-id>26</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Nunes-Costa, Magalhães,
                    G-Fernandes, Cardoso and Empadinhas.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Nunes-Costa, Magalhães, G-Fernandes, Cardoso and
                    Empadinhas</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the
                        Creative Commons Attribution License (CC BY). The use, distribution or
                        reproduction in other forums is permitted, provided the original author(s)
                        and the copyright owner(s) are credited and that the original publication in
                        this journal is cited, in accordance with accepted academic practice. No
                        use, distribution or reproduction is permitted which does not comply with
                        these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The neurotoxin β-<italic>N</italic>-methylamino-L-alanine (BMAA) is a
                    natural non-proteinogenic diamino acid produced by several species of both
                    prokaryotic (cyanobacteria) and eukaryotic (diatoms and dinoflagellates)
                    microorganisms. BMAA has been shown to biomagnify through the food chain in some
                    ecosystems, accumulating for example in seafood such as shellfish and fish,
                    common dietary sources of BMAA whose ingestion may have possible neuronal
                    consequences. In addition to its excitotoxic potential, BMAA has been implicated
                    in protein misfolding and aggregation, inhibition of specific enzymes and
                    neuroinflammation, all hallmark features of neurodegenerative diseases. However,
                    the exact molecular mechanisms of neurotoxicity remain to be elucidated in
                    detail. Although BMAA is commonly detected in its free form, complex
                    BMAA-containing molecules have also been identified such as the paenilamicins,
                    produced by an insect gut bacterial pathogen. On the other hand, production of
                    BMAA or BMAA-containing molecules by members of the human gut microbiota, for
                    example by non-photosynthetic cyanobacteria, the Melainabacteria, remains only
                    hypothetical. In any case, should BMAA reach the gut it may interact with cells
                    of the mucosal immune system and neurons of the enteric nervous system (ENS) and
                    possibly target the mitochondria. Here, we review the available evidence and
                    hint on possible mechanisms by which chronic exposure to dietary sources of this
                    microbial neurotoxin may drive protein misfolding and mitochondrial dysfunction
                    with concomitant activation of innate immune responses, chronic low-grade gut
                    inflammation, and ultimately the neurodegenerative features observed across the
                    gut-brain axis in Parkinson’s disease (PD).</p>
</abstract>
<kwd-group>
<kwd>Parkinson’s disease</kwd>
<kwd>mitochondrial dysfunction</kwd>
<kwd>innate immunity</kwd>
<kwd>neurodegeneration</kwd>
<kwd>microbial β-<italic>N</italic>-Methylamino-L-alanine (BMAA)</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Fundação para a Ciência e a
                            Tecnologia<named-content content-type="fundref-id">10.13039/501100001871</named-content></funding-source>
</award-group>
<award-group>
<funding-source id="cn002">European Regional Development Fund<named-content content-type="fundref-id">10.13039/501100008530</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="110"></ref-count>
<page-count count="9"></page-count>
<word-count count="7857"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Chronic Exposure to BMAA</title>
<p>Microbial metabolism is an endless source of compounds with diverse biological
                activities ranging from vitamins to toxins, with a tremendous impact on human health
                and disease. The neurotoxin β-<italic>N</italic>-methylamino-L-alanine
                (BMAA) is an example of a microbial compound to which humans are differently exposed
                but whose health impacts are still not fully understood, even though current
                evidence points to an association between BMAA exposure and susceptibility to
                neurogenerative diseases.</p>
<p>Crucial to understanding how humans may be chronically exposed to BMAA and thus to
                evaluate how they may be more susceptible to neurodegenerative diseases is
                identifying its natural producers and how this neurotoxin moves through the food
                chain. On the island of Guam, symbiotic <italic>Nostoc</italic> cyanobacteria
                associated with the roots of cycad plants have historically been considered the main
                source of BMAA in the ecosystem. The hypothesis, in its most recent formulation,
                states that BMAA is produced by cycad-associated cyanobacteria, accumulates in cycad
                seeds consumed by fruit bats or flying foxes that were part of the local
                population’s diet, or directly used to make flour, thus biomagnifying in the
                food chain. According to this hypothesis, chronic exposure to BMAA through the
                ingestion of contaminated plants and animals would, therefore, be a contributing
                factor in the development of the ALS-PDC pathology in Guam residents (Bradley and
                Mash, <xref ref-type="bibr" rid="B12">2009</xref>). High-incidence clusters of this
                condition have also been described in populations from the Kii peninsula of Japan
                and from western New Guinea, both genetically distinct from each other and from the
                Guam population but also with documented use of cycad-derived products, supporting
                an environmental etiology (Ince and Codd, <xref ref-type="bibr" rid="B54">2005</xref>). Elsewhere, contaminated fish and shellfish have been proposed as
                a significant source of human exposure through biomagnification of BMAA produced not
                only by marine cyanobacteria but also by dinoflagellates and diatoms (Brand et al.,
                    <xref ref-type="bibr" rid="B13">2010</xref>; Jonasson et al., <xref ref-type="bibr" rid="B58">2010</xref>; Banack et al., <xref ref-type="bibr" rid="B5">2014</xref>; Jiang et al., <xref ref-type="bibr" rid="B55">2014</xref>; Lage et
                al., <xref ref-type="bibr" rid="B61">2014</xref>). A few studies have investigated
                if crops irrigated with BMAA-contaminated water can bioaccumulate BMAA, and although
                this seems to be the case under laboratory-controlled conditions, the only study
                that conducted a field experiment with BMAA-containing water from a cyanobacterial
                bloom found no BMAA accumulation in the irrigated vegetables (Contardo-Jara et al.,
                    <xref ref-type="bibr" rid="B27">2014</xref>, <xref ref-type="bibr" rid="B28">2018</xref>; Esterhuizen-Londt and Pflugmacher, <xref ref-type="bibr" rid="B40">2019</xref>). Thus, the BMAA exposure risk associated with the consumption of
                vegetables irrigated with cyanobacterial bloom-contaminated water remains to be
                demonstrated.</p>
<p>Cyanobacteria are widespread producers of BMAA, as shown by several studies employing
                highly selective analytical methods that confirmed the presence of BMAA in
                lab-maintained cyanobacterial cultures of different genera belonging to sections I
                    (<italic>Chroococcus</italic>, <italic>Merismopedia</italic>,
                    <italic>Mycrocystis</italic>, <italic>Synechocystis</italic>), II
                    (<italic>Myxosarcina</italic>), III (<italic>Leptolyngbya</italic>,
                    <italic>Lyngbya</italic>, <italic>Oscillatoria</italic>) and IV
                    (<italic>Anabaena</italic>, <italic>Nostoc</italic>; Banack et al., <xref ref-type="bibr" rid="B4">2007</xref>; Li et al., <xref ref-type="bibr" rid="B68">2010</xref>; Spáčil et al., <xref ref-type="bibr" rid="B102">2010</xref>; Downing et al., <xref ref-type="bibr" rid="B36">2011</xref>;
                Berntzon et al., <xref ref-type="bibr" rid="B8">2013</xref>; Combes et al., <xref ref-type="bibr" rid="B26">2013</xref>; Jiang et al., <xref ref-type="bibr" rid="B56">2013</xref>; Lage et al., <xref ref-type="bibr" rid="B60">2016a</xref>; Monteiro et al., <xref ref-type="bibr" rid="B77">2017</xref>;
                Metcalf et al., <xref ref-type="bibr" rid="B75">2017</xref>; Violi et al., <xref ref-type="bibr" rid="B108">2019</xref>). Although cyanobacteria are
                photoautotrophic bacteria, a nonphotosynthetic clade of divergent cyanobacteria
                named Melainabacteria was identified in groundwater, tap water, wastewater treatment
                plants and also as members of the human gut microbiota (Di Rienzi et al., <xref ref-type="bibr" rid="B34">2013</xref>; Soo et al., <xref ref-type="bibr" rid="B101">2014</xref>). The production of BMAA by members of the gut
                microbiota would be another possible route of chronic exposure but this hypothesis
                has not been investigated thus far (Brenner, <xref ref-type="bibr" rid="B17">2013</xref>). However, the fact that the BMAA biosynthetic genes have not been
                identified in any of its natural producers prevents further speculation on whether
                Melainabacteria share the BMAA biosynthetic machinery with their photosynthetic
                counterparts. Indeed, and despite the ever-increasing interest in BMAA, the
                biosynthetic origins of this nonproteinogenic amino acid remain elusive and the
                proposed metabolic routes are still hypothetical (Brenner et al., <xref ref-type="bibr" rid="B16">2003</xref>; Downing and Downing, <xref ref-type="bibr" rid="B35">2016</xref>; Nunn and Codd, <xref ref-type="bibr" rid="B81">2017</xref>). Recently, it was argued that cyanobacterial BMAA may originate
                from the hydrolysis of a methylated peptide (Nunn and Codd, <xref ref-type="bibr" rid="B81">2017</xref>) and indeed, BMAA occurs in nature in a bound form
                in at least one family of secondary metabolites, the paenilamicins (Müller
                et al., <xref ref-type="bibr" rid="B78">2014</xref>). These peptides are produced by
                the honey bee intestinal pathogen <italic>Paenibacillus larvae</italic> by a hybrid
                nonribosomal peptide/polyketide synthase (NRPS/PKS) and the genetic basis for the
                synthesis of the two BMAA moieties has been elucidated (Müller et al., <xref ref-type="bibr" rid="B78">2014</xref>). Notably, homologs of the NRPS modules
                responsible for the BMAA moieties could be detected in some bacterial genera, none
                belonging to the phylum Cyanobacteria. Still, the possibility that free BMAA can
                originate in some organisms through the breakdown of more complex molecules such as
                the paenilamicins deserves further investigation.</p>
</sec>
<sec id="s2">
<title>The Gut-Brain Axis</title>
<p>Humans are constantly exposed to a wide variety of microbial metabolites including
                BMAA and the gastrointestinal (GI) tract represents the main interface, not only
                because it is in direct contact with microbial metabolites present in food and
                drinking water, but also because it is the most heavily colonized surface housing
                metabolically-active microorganisms at least as numerous as human cells. This
                enormous amount and diversity of microbes contributes with a giant genomic blueprint
                far superior to that of the human genome, and its products, together with dietary
                metabolites, have a pronounced impact on human biochemistry and physiology (Ley et
                al., <xref ref-type="bibr" rid="B67">2006</xref>; Sekirov et al., <xref ref-type="bibr" rid="B99">2010</xref>; Shibata et al., <xref ref-type="bibr" rid="B100">2017</xref>). Intestinal microbes are known to be essential for the development
                and functionality of the host’s immune responses, for the regulation of gut
                motility, for maintenance of the intestinal barrier integrity and nutrient
                absorption, for the metabolism of therapeutic drugs, and prevention over inadvertent
                environmental exposure to toxic compounds (Sekirov et al., <xref ref-type="bibr" rid="B99">2010</xref>; Cryan and Dinan, <xref ref-type="bibr" rid="B30">2012</xref>). An imbalance in the normal microbiota elicited by diet, GI
                infection, stress or antibiotics, can significantly alter microbiome homeostasis
                with negative impacts on health (Stecher and Hardt, <xref ref-type="bibr" rid="B103">2008</xref>; Claesson et al., <xref ref-type="bibr" rid="B24">2012</xref>;
                Collins et al., <xref ref-type="bibr" rid="B25">2012</xref>; Cryan and Dinan, <xref ref-type="bibr" rid="B30">2012</xref>; Lee and Hase, <xref ref-type="bibr" rid="B66">2014</xref>). In this article, we focus on the
                microbial-produced neurotoxin BMAA discussing how chronic exposure can affect the GI
                and nervous systems and lead to disease.</p>
<p>The human gut has its own nervous system, the enteric nervous system (ENS), a vast
                and complex network of neurons and glial cells within the bowel, grouped into
                ganglia located in the myenteric and the submucosal plexuses (Gershon, <xref ref-type="bibr" rid="B47">1999</xref>; Lebouvier et al., <xref ref-type="bibr" rid="B64">2009</xref>). The ENS depends extensively on the microbiota to
                develop neuronal electrophysiological properties, such as membrane action potential
                and sensory neuron excitability (McVey Neufeld et al., <xref ref-type="bibr" rid="B73">2013</xref>), and it normally communicates with the central
                nervous system (CNS) <italic>via</italic> a bi-directional homeostatic route
                designated the gut-brain axis, involving neural, metabolic, hormonal and
                immunological signaling (Mayer, <xref ref-type="bibr" rid="B71">2011</xref>; Collins
                et al., <xref ref-type="bibr" rid="B25">2012</xref>; Cryan and Dinan, <xref ref-type="bibr" rid="B30">2012</xref>). The vagus nerve is the main
                bidirectional pathway connecting the viscera to the brain (Forsythe et al., <xref ref-type="bibr" rid="B44">2014</xref>). Microbial metabolites, namely
                neurotransmitters, can reach and affect brain development and functions through the
                gut-brain axis (Sekirov et al., <xref ref-type="bibr" rid="B99">2010</xref>; Collins
                et al., <xref ref-type="bibr" rid="B25">2012</xref>; Cryan and Dinan, <xref ref-type="bibr" rid="B30">2012</xref>). Gut microbiota composition and dysbiosis
                also play a role in conditions of the CNS, including Parkinson’s disease
                (PD; Finegold et al., <xref ref-type="bibr" rid="B42">2002</xref>; Parracho et al.,
                    <xref ref-type="bibr" rid="B88">2005</xref>; Berer et al., <xref ref-type="bibr" rid="B6">2011</xref>; Sampson et al., <xref ref-type="bibr" rid="B97">2016</xref>).</p>
</sec>
<sec id="s3">
<title>Gastrointestinal Disorders and Neurodegeneration: The Case of PD</title>
<p>PD is usually defined as a movement disorder characterized by motor symptoms, such as
                tremor, postural imbalance, bradykinesia and rigidity (Obeso et al., <xref ref-type="bibr" rid="B82">2010</xref>). The histopathological postmortem hallmark of PD is
                the presence of α-synuclein-containing (ASYN) insoluble fibrous aggregates,
                termed Lewy bodies (LBs), accompanied by the progressive loss of dopaminergic
                neurons in the substantia nigra pars compacta (SNpc) in the CNS. Major causative
                gene mutations in familial PD are linked to proteins involved in mitochondrial
                metabolism and dynamics (Cardoso et al., <xref ref-type="bibr" rid="B21">2005</xref>), which highlights a key role of mitochondria in the PD
                neurodegenerative process.</p>
<p>Sporadic PD has a long prodromal period during which several other features develop,
                namely olfactory impairment, sleep disturbances and depression (Reichmann et al.,
                    <xref ref-type="bibr" rid="B92">2009</xref>). Additionally, GI dysfunction that
                includes dysphagia, gastroparesis and severe constipation (Wingate, <xref ref-type="bibr" rid="B110">1999</xref>; Pfeiffer, <xref ref-type="bibr" rid="B89">2003</xref>; Rao and Gershon, <xref ref-type="bibr" rid="B91">2016</xref>) may
                precede the onset of motor symptoms by many years (Savica et al., <xref ref-type="bibr" rid="B98">2009</xref>; Cersosimo and Benarroch, <xref ref-type="bibr" rid="B23">2012</xref>). LBs were found in both the myenteric plexus and
                submucosal plexus neurons of postmortem PD patients (Wakabayashi et al., <xref ref-type="bibr" rid="B109">1988</xref>; Braak et al., <xref ref-type="bibr" rid="B10">2006</xref>) and even in presymptomatic cases (Braak et al.,
                    <xref ref-type="bibr" rid="B10">2006</xref>). Indeed, accumulating evidence
                obtained from biopsy studies confirmed the presence of LBs in organs innervated by
                the vagus nerve such as the salivary glands, stomach, duodenum, colon and in the
                rectum (Cersosimo, <xref ref-type="bibr" rid="B22">2015</xref>), indicating that the
                vagus nerve is the obvious route through which the disease spreads between the gut
                and the brain, leading to the hypothesis that a toxin or pathogen can trigger the
                disease (Hawkes et al., <xref ref-type="bibr" rid="B51">2007</xref>; Brenner, <xref ref-type="bibr" rid="B17">2013</xref>; Alam et al., <xref ref-type="bibr" rid="B2">2017</xref>). Braak et al. (<xref ref-type="bibr" rid="B11">2003</xref>) showed that the progression of LBs, the PD histopathological
                marks, is in agreement with the hypothesis that a pathogen in the GI tract may
                trigger abnormal ASYN processing and then spread <italic>via</italic> retrograde
                axonal vagus transport from the ENS to the CNS and that the GI symptoms observed in
                the vast majority of PD patients are pre-motor manifestations of PD. Notably, ASYN
                fibrils injected in mice duodenum were able to propagate to the brain months after
                injection (Van Den Berge et al., <xref ref-type="bibr" rid="B107">2019</xref>) with
                propagation occurring through the vagus since it could be inhibited by vagotomy (Kim
                et al., <xref ref-type="bibr" rid="B59">2019</xref>). Indeed, individuals that
                underwent full truncal vagotomy had a decreased risk for subsequent PD, strongly
                implicating the vagus nerve in PD pathogenesis and again corroborating the
                involvement of an enteric pathogen or toxin (Svensson et al., <xref ref-type="bibr" rid="B105">2015</xref>).</p>
</sec>
<sec id="s4">
<title>Amino Acid Misincorporation, Protein Folding and Neurodegeneration</title>
<p>Neurodegenerative disorders share similar histopathological hallmarks of protein
                misfolding and aggregation, even though the protein component and affected brain
                region may differ (Ross and Poirier, <xref ref-type="bibr" rid="B95">2004</xref>).
                These neurodegenerative disorders are mostly sporadic without a known etiological
                factor, with aging being the most relevant risk factor. Although most proteins
                encoded in the human genome can be removed by cellular quality systems when damaged,
                some polypeptides are prone to misfold and aggregate into toxic oligomers.
                Interestingly, these protein aggregates can further downregulate the activities of
                proteolytic pathways since they are protease-resistant. Thus, accumulation of
                protein aggregates in different neurodegenerative diseases and disruption of
                translational fidelity in terminally differentiated post-mitotic neurons are
                potential pathways leading to cell death (Lee et al., <xref ref-type="bibr" rid="B65">2006</xref>).</p>
<p>Hundreds of amino acids are known to occur in nature although only 22 are used in
                protein synthesis. Some of those non-proteinogenic amino acids can be mistakenly
                charged onto tRNA and misincorporated into proteins, potentially causing loss of
                function and/or misfolding (Bullwinkle et al., <xref ref-type="bibr" rid="B18">2014</xref>). Primary metabolites such as ornithine, homoserine, and
                homocysteine are substrates for aminoacyl-tRNA synthetases, but cellular quality
                control mechanisms can detect their mischarging onto tRNA and prevent their
                inclusion into proteins. Other non-proteinogenic amino acids, though, are secondary
                metabolites produced by certain microbial species and can elude quality control
                pathways of nonproducing organisms, behaving as toxins (Bullwinkle et al., <xref ref-type="bibr" rid="B18">2014</xref>). It has been speculated that these
                dietary or microbial-produced toxic amino acids could, in addition to host genetic
                factors, represent an environmental trigger for the onset of neurodegeneration
                (Rodgers, <xref ref-type="bibr" rid="B94">2014</xref>).</p>
<p>Accumulating evidence suggests that this is the case for BMAA, which has been
                reported to be misincorporated into human proteins in place of serine, resulting in
                protein misfolding and aggregation, ER stress and apoptosis (Dunlop et al., <xref ref-type="bibr" rid="B39">2013</xref>; Glover et al., <xref ref-type="bibr" rid="B48">2014</xref>; Main et al., <xref ref-type="bibr" rid="B69">2016</xref>). In light of these observations, BMAA misincorporation into ASYN
                could be a possible mechanism of BMAA-induced neurodegeneration, since serine
                phosphorylation is heavily correlated with ASYN aggregation. It is conceived that
                the vast majority of ASYN present in Lewy body aggregates is phosphorylated at
                serine 129 (S129; Oueslati, <xref ref-type="bibr" rid="B86">2016</xref>), however,
                the modulation of ASYN aggregation by S129 phosphorylation is still a matter of
                debate, since <italic>in vivo</italic> studies demonstrate that this association is
                far more complex than what may appear (McFarland et al., <xref ref-type="bibr" rid="B72">2009</xref>). Nonetheless, BMAA misincorporation in this
                position could provoke an imbalance in the extension of S129 phosphorylation,
                thereby promoting ASYN aggregation. Interestingly, S87 phosphorylation was found to
                inhibit ASYN aggregation and the substitution of serine by BMAA in this position
                could hypothetically reshape the sequence milieu and therefore reduce phosphorylated
                S87, increasing the propensity of ASYN to aggregate (Oueslati et al., <xref ref-type="bibr" rid="B87">2012</xref>).</p>
<p>While the observation that BMAA interacts very strongly with proteins causing their
                misfolding has not been disputed, some groups have failed to detect incorporation of
                BMAA into the primary structure of proteins thus calling into question the role of
                the misincorporation hypothesis in explaining BMAA’s observed neurotoxic
                effects (Beri et al., <xref ref-type="bibr" rid="B7">2017</xref>; Onselen et al.,
                    <xref ref-type="bibr" rid="B85">2017</xref>). Subsequently, alternative
                mechanisms have been investigated and BMAA has been found to strongly associate with
                melanin, to selectively inhibit the activity of certain enzymes and to interfere
                with and disrupt protein refolding <italic>in vitro</italic> by associating with
                proteins through electrostatic interactions strong enough to resist TCA
                precipitation and subsequent washing with SDS or DTT (van Onselen and Downing, <xref ref-type="bibr" rid="B83">2018</xref>). In particular, the interaction of BMAA
                with melanin and neuromelanin, which seem to have an important role in neurotoxin
                sequestration and neurodegeneration, as well as its ability to inhibit human
                catalase, an enzyme directly involved in the detoxification of
                β-amyloid-linked cellular toxicity, have recently been proposed to also
                contribute to BMAA’s neurotoxicity (Delcourt et al., <xref ref-type="bibr" rid="B33">2018</xref>; van Onselen and Downing, <xref ref-type="bibr" rid="B84">2019</xref>). Whether BMAA causes proteins to misfold due to
                eventual misincorporation into their primary structure or through strong
                electrostatic interactions with nascent chains remains to be confirmed (Dunlop and
                Guillemin, <xref ref-type="bibr" rid="B38">2019</xref>).</p>
<p>As indicated above, supporting evidence for BMAA’s putative role in
                triggering neurodegenerative diseases comes from the island of Guam, where endemic
                ALS-PDC has been linked to chronic exposure to BMAA in the diet of Guam residents
                (Bradley and Mash, <xref ref-type="bibr" rid="B12">2009</xref>). Other factors have
                been proposed to be involved in the etiology of Guam ALS-PDC, namely secondary
                hyperparathyroidism due to low ingestion of calcium and magnesium together with high
                aluminum consumption, since deposits of these substances were observed in the brains
                of affected Guam residents (Garruto et al., <xref ref-type="bibr" rid="B46">1984</xref>). Although we cannot fully discard this as a potential contributing
                factor, a study failed to prove altered levels of calcium, magnesium and heavy metal
                levels in patient blood, urine and hair. Parathyroid hormone and serum phosphorus
                levels—indicators of secondary hyperparathyroidism—were also
                reported to be within the normal range in Guam affected people (Ahlskog et al.,
                    <xref ref-type="bibr" rid="B1">1995</xref>), rendering the heavy metal
                hypothesis unlikely to be the principal cause of endemic ALS-PDC. In addition, there
                is no report of secondary hyperparathyroidism treatment being successful in ALS-PDC
                patients. Nonetheless, BMAA was detected in brain proteins from PD, AD, and ALS
                patients but not in controls (Dunlop et al., <xref ref-type="bibr" rid="B39">2013</xref>), and was also recently detected in the CNS of
                    <italic>antemortem</italic> human individuals, including in one ALS patient
                where it was suggested to act as a disease-potentiating agent together with other
                environmental factors (Berntzon et al., <xref ref-type="bibr" rid="B9">2015</xref>).
                Moreover, rats treated with BMAA display ALS-like neurological impairment (de Munck
                et al., <xref ref-type="bibr" rid="B32">2013</xref>). Other studies have, however,
                failed to confirm such results casting doubt on the selectivity and reliability of
                the analytical methods employed by other groups (Meneely et al., <xref ref-type="bibr" rid="B74">2016</xref>). On the other hand, a study with vervet monkeys
                found that dietary BMAA triggers the formation of neurofibrillary tangles and
                Aβ plaques characteristic of ALS-PDC and Alzheimer’s disease,
                whereas the co-administration of L-serine was shown to have a neuroprotective effect
                (Cox et al., <xref ref-type="bibr" rid="B29">2016</xref>). The latter finding is
                consistent with BMAA being a substrate for seryl-tRNA synthetase and suggests that
                inhibition of the proposed BMAA misincorporation into brain proteins by L-serine may
                be linked with prevention of BMAA’s neurodegenerative effects (Main et al.,
                    <xref ref-type="bibr" rid="B69">2016</xref>). Intriguingly, conversion of L-BMAA
                into D-BMAA has been detected in the liver and in the brain of mice, bringing
                additional complexity into the already puzzling field of BMAA research (Metcalf et
                al., <xref ref-type="bibr" rid="B75">2017</xref>). More recently, an <italic>in
                    vitro</italic> study revealed that human liver hepatocyte and intestinal
                epithelial cell cultures are incapable of metabolizing BMAA, suggesting the absence
                of detoxification pathways that should protect against dietary exposure to this
                toxin (Downing et al., <xref ref-type="bibr" rid="B37">2019</xref>).</p>
</sec>
<sec id="s5">
<title>Mitochondrial-Driven Innate Immunity Activation: A Possible Link Between BMAA and
                Neurodegeneration</title>
<p>Neuronal loss is the ultimate consequence in the pathophysiology of neurodegenerative
                diseases, although the specificity of the neurons that degenerate is quite
                distinguishable. While in AD the entorhinal cortical and hippocampal neurons are the
                first to be affected, in PD and ALS the SNpc and the motor neurons are the first to
                perish, respectively (Martin, <xref ref-type="bibr" rid="B70">1999</xref>). Despite
                these distinct features, neurodegenerative diseases share many common
                characteristics such as mitochondrial failure and marked proinflammatory profiles
                (Gan et al., <xref ref-type="bibr" rid="B45">2018</xref>). It is also well
                established that in most neurodegenerative diseases, the activity of the electron
                transport chain (ETC) complexes are consistently impaired, along with aberrant
                mitochondrial dynamics, higher fragmentation, swelling with deformed
                    <italic>cristae</italic> and increased reactive oxygen species (ROS) production
                (Johri and Beal, <xref ref-type="bibr" rid="B57">2012</xref>; Hroudová et
                al., <xref ref-type="bibr" rid="B53">2014</xref>; Muyderman and Chen, <xref ref-type="bibr" rid="B79">2014</xref>). Furthermore, studies in post-mortem
                brain samples and analysis of cerebrospinal fluid (CSF) of AD, PD and ALS patients
                have demonstrated a sheer correlation between disease and up-regulation of several
                proinflammatory cytokines involved in the innate immune response (Stephenson et al.,
                    <xref ref-type="bibr" rid="B104">2018</xref>). The cause of these striking
                neuroinflammatory events is very often intertwined with loss of neuronal
                mitochondria fitness. Upon a given damage, mitochondria expose danger-associated
                molecular patterns (DAMPs; Grazioli and Pugin, <xref ref-type="bibr" rid="B49">2018</xref>), signals that are recognized by cellular mechanisms involving
                pattern recognition receptors (PRR) and which are divided into four families:
                toll-like receptors (TLR), Rig-1-like receptors (RLR), Nod-like receptors (NLR) and
                C-type lectin receptors (CLR). When activated by mitochondrial DAMPS, these PRR
                receptors can induce the upregulation of the NF-kB pathway, leading to the release
                of proinflammatory cytokines, such as TNFα and IL-1β, the latter
                through the activation of the NLRP3 inflammasome (Cardoso and Empadinhas, <xref ref-type="bibr" rid="B20">2018</xref>). Moreover, mitochondrial ROS
                overproduction can also activate the inflammasome, thus amplifying the overall
                inflammatory response (Saint-Georges-Chaumet and Edeas, <xref ref-type="bibr" rid="B96">2016</xref>).</p>
<p>Mitochondria are unique organelles with their origins tracing back to an ancient
                α-proteobacterial lineage (Hibbing et al., <xref ref-type="bibr" rid="B52">2010</xref>) that grants them exclusive features such as their own DNA, an
                independent replication process, their own ribosomes, the mitoribosomes, and
                bacterial-type phospholipids such as cardiolipin (Cardoso and Empadinhas, <xref ref-type="bibr" rid="B20">2018</xref>; Grazioli and Pugin, <xref ref-type="bibr" rid="B49">2018</xref>). Bacterial populations compete for nutrients in
                many ways, one being the production of noxious substances that evolved to control or
                kill competitors. In fact, this is a common strategy used for the discovery of new
                potential antibiotics (Hibbing et al., <xref ref-type="bibr" rid="B52">2010</xref>).
                Mitochondria’s resemblance with bacteria makes them natural targets of many
                microbial byproducts and, indeed, many examples of microbial substances targeting
                mitochondria have been identified. <italic>Streptococcus pneumoniae</italic>, for
                example, produces pneumolysin, a pore-forming substance that causes neuronal death
                by specifically targeting mitochondria (Braun et al., <xref ref-type="bibr" rid="B15">2007</xref>). Some other toxins do not even require the actual
                presence of bacteria to promote mitochondrial failure. Although the molecular
                mechanisms are still to be explored, <italic>Staphylococcus aureus</italic>
                α-toxin and <italic>Helicobacter pylori</italic> vacuolating cytotoxin
                (VacA) can promote cytotoxicity through mitochondrial impairment (Arnoult et al.,
                    <xref ref-type="bibr" rid="B3">2009</xref>). It should be noted here that BMAA
                may also have the ability to induce mitochondrial dysfunction (Beri et al., <xref ref-type="bibr" rid="B7">2017</xref>). <italic>In vitro</italic> studies with
                NSC-34 cells, a cell line of motor neurons showed that BMAA elicited a pronounced
                decrease in oxidative phosphorylation, altered calcium homeostasis and exacerbated
                ROS production. In addition, treatment with BMAA dramatically decreased N2a neuronal
                cell line viability that was assessed by measuring the activity of the mitochondrial
                enzyme succinate dehydrogenase (SD; Takser et al., <xref ref-type="bibr" rid="B106">2016</xref>). In brain samples from the population of the Kii peninsula of
                Japan, mitochondrial disruption has also been shown to occur leading to increased
                ROS production (Hata et al., <xref ref-type="bibr" rid="B50">2018</xref>).
                Unfortunately, the mechanism of action remains elusive.</p>
<p>Recent findings have confirmed that, in addition to the deleterious effects on
                mitochondria, BMAA exposure was also associated with the proinflammatory profile
                observed in neurodegenerative diseases. BMAA administration to rats was able to
                reproduce the neuronal phenotype of ALS, concomitantly with a strong expression of
                proinflammatory cytokines (Michaelson et al., <xref ref-type="bibr" rid="B76">2017</xref>). Remarkably, BMAA was able to promote the upregulation of Glial
                Fibrillary Acidic Protein (GFAP) and, consequently, an evident astrogliosis in a rat
                model of ALS-PDC (Cai et al., <xref ref-type="bibr" rid="B19">2018</xref>). Also,
                BMAA triggered cytotoxic effects in a RAW246.7 cell line and in BV-2 microglial
                cells (Takser et al., <xref ref-type="bibr" rid="B106">2016</xref>), which confers
                potential immunomodulatory capacity to this neurotoxin.</p>
</sec>
<sec id="s6" sec-type="conclusion">
<title>Conclusion</title>
<p>Although considerable attention has been dedicated to BMAA research over the past
                decades, many aspects of this field remain uncertain. The fact that early analytical
                methods for BMAA detection were found to be unreliable hindered further progress
                (Faassen, <xref ref-type="bibr" rid="B41">2014</xref>) and even with the
                implementation of more selective methods some conflicting results are still
                reported, particularly when it comes to assessing the BMAA biosynthetic potential of
                cyanobacterial strains. Such results increasingly suggest that BMAA production by
                cyanobacteria may be transient, inconsistent in laboratory cultures, and subject to
                fluctuations provoked by certain stimuli such as nitrogen availability (Downing et
                al., <xref ref-type="bibr" rid="B36">2011</xref>; Monteiro et al., <xref ref-type="bibr" rid="B77">2017</xref>). The fact is that the biological functions of this
                diamino acid in nature are still unknown. The few studies conducted on its natural
                producers have concluded that it interferes with nitrogen metabolism and have
                hypothesized an allelopathic role for BMAA, a common biological phenomenon by which
                metabolites produced by some organisms affect certain physiological traits of others
                (Lage et al., <xref ref-type="bibr" rid="B62">2016b</xref>; Popova et al., <xref ref-type="bibr" rid="B90">2018</xref>). In the case of the BMAA-containing
                paenilamicins, production of the compound was shown to impact competing bacterial
                populations in the larval gut thus confirming its allelopathic role (Müller
                et al., <xref ref-type="bibr" rid="B78">2014</xref>). Although the ability of human
                gut microbiota to produce or be impacted by BMAA or BMAA-containing molecules is
                still unknown and warrants future investigation, there is little doubt that seafood
                and particularly marine bivalves can be a non-negligible source of dietary BMAA,
                which justifies further epidemiological studies to assess the real risk posed by
                their consumption (Lance et al., <xref ref-type="bibr" rid="B63">2018</xref>).</p>
<p>Another topic warranting future investigation in this field is the identification of
                host genetic factors underlying individual predisposition to developing sporadic
                neurodegenerative diseases as a result of chronic BMAA exposure. Indeed, besides
                well-studied mutations that cause familial neurodegenerative diseases, some genetic
                polymorphisms have been associated with the susceptibility of their sporadic
                counterparts (Rocchi et al., <xref ref-type="bibr" rid="B93">2003</xref>; Bras and
                Singleton, <xref ref-type="bibr" rid="B14">2009</xref>). We propose that susceptible
                individuals with certain genetic polymorphisms, including in elements of the
                translational machinery (Bullwinkle et al., <xref ref-type="bibr" rid="B18">2014</xref>), may more often misincorporate BMAA into aggregation-prone
                proteins whose accumulation in neurons may trigger the onset of neurodegeneration,
                initially in the ENS and ultimately in the CNS, owing to retrograde transport
                through the vagus nerve, or plasma, to the brain. Additionally, microbial
                metabolites can bypass the intestinal mucosa barrier due to increased
                permeabilization of the gut barrier, which is known to be increased in PD (Forsyth
                et al., <xref ref-type="bibr" rid="B43">2011</xref>) and would facilitate BMAA
                toxicity. Aging accompanied with a decrease in the immune response
                (immunosenescence) often attributed to PD is greatly associated with a leaky gut
                (Nagpal et al., <xref ref-type="bibr" rid="B80">2018</xref>). Also of note, a study
                performed by Dawson et al. (<xref ref-type="bibr" rid="B31">1998</xref>)
                demonstrated that male rats were more susceptible to BMAA-induced toxicity than
                females, a very interesting observation given that PD has a higher incidence in
                males than females.</p>
<p>In any case and as summarized in this review, BMAA effects in human cell lines and in
                animals are consistent with the hypothesis that chronic exposure to this neurotoxin
                can trigger features of sporadic neurodegenerative diseases such as PD (<xref ref-type="fig" rid="F1">Figure 1</xref>). In this regard, it is reasonable to
                hypothesize that BMAA may promote protein misfolding, mitochondrial dysfunction and
                chronic innate immune activation in genetically susceptible individuals, initially
                in the ENS and later in the CNS by means of retrograde transport
                    <italic>via</italic> the vagus nerve, and ultimately leading to brain
                neurodegeneration (<xref ref-type="fig" rid="F1">Figure 1</xref>). The toxicological
                evidence from these studies is on its own sufficient to drive research towards the
                identification of the biosynthetic pathways and biological functions of this diamino
                acid in its natural producers, in-depth studies tracking BMAA through the food web
                in the various ecosystems, and epidemiological studies in populations exposed to
                BMAA-containing seafood. Only with this information, we will be able to accurately
                link the missing dots in the old but still controversial hypothesis of a BMAA-driven
                cause for sporadic neurodegenerative diseases in humans.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The “neurotoxin hypothesis” for sporadic neurodegenerative
                        diseases such as Parkinson’s disease (PD). Chronic intestinal
                        exposure to β-<italic>N</italic>-methylamino-L-alanine (BMAA) may
                        trigger neurodegeneration by promoting protein misfolding, mitochondrial
                        dysfunction and innate immune responses in genetically susceptible
                        individuals, initially in the enteric nervous system (ENS) and later in the
                        central nervous system (CNS) through retrograde transport
                            <italic>via</italic> the vagus nerve. </p>
</caption>
<graphic xlink:href="fnagi-12-00026-g0001"></graphic>
</fig>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>NE and SC: conceptualization. DN-C, JM, SC and NE: investigation. SC and NE: funding.
                DN-C, JM, MG-F, SC and NE: writing. </p>
</sec>
<sec id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial
                or financial relationships that could be construed as a potential conflict of
                interest. </p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> We acknowledge Fundação para a
                    Ciência e a Tecnologia (FCT) and COMPETE 2020, Operational Programme for
                    Competitiveness and Internationalization (POCI) through FEDER for projects
                    UID/NEU/04539/2019 (POCI-01-0145-FEDER-007440), POCI-01-0145-FEDER-030712 and
                    Ph.D. fellowships SFRH/BD/117777/2016 to DN-C and PD/BD/146409/2019 to JM. We
                    also acknowledge the European Regional Development Fund Centro2020 Regional
                    Operational Programme (CENTRO-01-0145-FEDER-000012-HealthyAging2020), the
                    Faculty of Medicine, University of Coimbra (Project FMUC-PEPITA-2018) and Santa
                    Casa da Misericórdia de Lisboa—Mantero Belard Neurosciences
                    Prize 2016 (MB-40-2016).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlskog</surname><given-names>J.
                            E.</given-names></name><name><surname>Waring</surname><given-names>S.
                                C.</given-names></name><name><surname>Kurland</surname><given-names>L.
                                T.</given-names></name><name><surname>Petersen</surname><given-names>R.
                                C.</given-names></name><name><surname>Moyer</surname><given-names>T.
                                P.</given-names></name><name><surname>Harmsen</surname><given-names>W.
                                S.</given-names></name><etal></etal></person-group>. (<year>1995</year>).
                        <article-title>Guamanian neurodegenerative disease: investigation of the
                        calcium metabolism/heavy metal hypothesis</article-title>.
                        <source/>Neurology
                    <volume>45</volume>, <fpage>1340</fpage>–<lpage>1344</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.45.7.1340</pub-id><pub-id pub-id-type="pmid">7617195</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>M.</given-names></name><name><surname>Alam</surname><given-names>Q.</given-names></name><name><surname>Kamal</surname><given-names>M.</given-names></name><name><surname>Jiman-Fatani</surname><given-names>A.</given-names></name><name><surname>Azhar</surname><given-names>E.</given-names></name><name><surname>Khan</surname><given-names>M.</given-names></name><etal></etal></person-group>.
                        (<year>2017</year>). <article-title>Infectious agents and neurodegenerative
                        diseases: exploring the links</article-title>. <source/>Curr. Top. Med.
                        Chem.
                    <volume>17</volume>, <fpage>1390</fpage>–<lpage>1399</lpage>. <pub-id pub-id-type="doi">10.2174/1568026617666170103164040</pub-id><pub-id pub-id-type="pmid">28049398</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnoult</surname><given-names>D.</given-names></name><name><surname>Carneiro</surname><given-names>L.</given-names></name><name><surname>Tattoli</surname><given-names>I.</given-names></name><name><surname>Girardin</surname><given-names>S.
                                E.</given-names></name></person-group> (<year>2009</year>).
                        <article-title>The role of mitochondria in cellular defense against
                        microbial infection</article-title>. <source/>Semin. Immunol.
                    <volume>21</volume>, <fpage>223</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2009.05.009</pub-id><pub-id pub-id-type="pmid">19535268</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banack</surname><given-names>S.
                            A.</given-names></name><name><surname>Johnson</surname><given-names>H.
                                E.</given-names></name><name><surname>Cheng</surname><given-names>R.</given-names></name><name><surname>Cox</surname><given-names>P.
                                A.</given-names></name></person-group> (<year>2007</year>).
                        <article-title>Production of the neurotoxin BMAA by a marine
                        cyanobacterium</article-title>. <source/>Mar. Drugs
                    <volume>5</volume>, <fpage>180</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.3390/md504180</pub-id><pub-id pub-id-type="pmid">18463731</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banack</surname><given-names>S.
                            A.</given-names></name><name><surname>Metcalf</surname><given-names>J.
                                S.</given-names></name><name><surname>Bradley</surname><given-names>W.
                                G.</given-names></name><name><surname>Cox</surname><given-names>P.
                                A.</given-names></name></person-group> (<year>2014</year>).
                        <article-title>Detection of cyanobacterial neurotoxin
                        β-N-methylamino-L-alanine within shellfish in the diet of an ALS
                        patient in Florida</article-title>. <source/>Toxicon
                    <volume>90</volume>, <fpage>167</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2014.07.018</pub-id><pub-id pub-id-type="pmid">25123936</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berer</surname><given-names>K.</given-names></name><name><surname>Mues</surname><given-names>M.</given-names></name><name><surname>Koutrolos</surname><given-names>M.</given-names></name><name><surname>Rasbi</surname><given-names>Z.
                                A.</given-names></name><name><surname>Boziki</surname><given-names>M.</given-names></name><name><surname>Johner</surname><given-names>C.</given-names></name><etal></etal></person-group>.
                        (<year>2011</year>). <article-title>Commensal microbiota and myelin
                        autoantigen cooperate to trigger autoimmune demyelination</article-title>.
                        <source/>Nature
                    <volume>479</volume>, <fpage>538</fpage>–<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1038/nature10554</pub-id><pub-id pub-id-type="pmid">22031325</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beri</surname><given-names>J.</given-names></name><name><surname>Nash</surname><given-names>T.</given-names></name><name><surname>Martin</surname><given-names>R.
                                M.</given-names></name><name><surname>Bereman</surname><given-names>M.
                                S.</given-names></name></person-group> (<year>2017</year>).
                        <article-title>Exposure to BMAA mirrors molecular processes linked to
                        neurodegenerative disease</article-title>. <source/>Proteomics
                    <volume>17</volume>:<fpage>1700161</fpage>. <pub-id pub-id-type="doi">10.1002/pmic.201700161</pub-id><pub-id pub-id-type="pmid">28837265</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berntzon</surname><given-names>L.</given-names></name><name><surname>Erasmie</surname><given-names>S.</given-names></name><name><surname>Celepli</surname><given-names>N.</given-names></name><name><surname>Eriksson</surname><given-names>J.</given-names></name><name><surname>Rasmussen</surname><given-names>U.</given-names></name><name><surname>Bergman</surname><given-names>B.</given-names></name></person-group>
                        (<year>2013</year>). <article-title>BMAA inhibits nitrogen fixation in the
                        cyanobacterium nostoc sp. PCC 7120</article-title>. <source/>Mar.
                        Drugs
                    <volume>11</volume>, <fpage>3091</fpage>–<lpage>3108</lpage>. <pub-id pub-id-type="doi">10.3390/md11083091</pub-id><pub-id pub-id-type="pmid">23966039</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berntzon</surname><given-names>L.</given-names></name><name><surname>Ronnevi</surname><given-names>L.
                                O.</given-names></name><name><surname>Bergman</surname><given-names>B.</given-names></name><name><surname>Eriksson</surname><given-names>J.</given-names></name></person-group>
                        (<year>2015</year>). <article-title>Detection of BMAA in the human central
                        nervous system</article-title>. <source/>Neuroscience
                    <volume>292</volume>, <fpage>137</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.02.032</pub-id><pub-id pub-id-type="pmid">25725357</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H.</given-names></name><name><surname>de
                                Vos</surname><given-names>R. A.
                                I.</given-names></name><name><surname>Bohl</surname><given-names>J.</given-names></name><name><surname>Del
                                Tredici</surname><given-names>K.</given-names></name></person-group>
                        (<year>2006</year>). <article-title>Gastric α-synuclein
                        immunoreactive inclusions in Meissner’s and Auerbach’s
                        plexuses in cases staged for Parkinson’s disease-related brain
                        pathology</article-title>. <source/>Neurosci. Lett.
                    <volume>396</volume>, <fpage>67</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.11.012</pub-id><pub-id pub-id-type="pmid">16330147</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H.</given-names></name><name><surname>Rüb</surname><given-names>U.</given-names></name><name><surname>Gai</surname><given-names>W.
                                P.</given-names></name><name><surname>Del
                                Tredici</surname><given-names>K.</given-names></name></person-group>
                        (<year>2003</year>). <article-title>Idiopathic Parkinson’s disease:
                        Possible routes by which vulnerable neuronal types may be subject to
                        neuroinvasion by an unknown pathogen</article-title>. <source/>J. Neural
                        Transm.
                    <volume>110</volume>, <fpage>517</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-002-0808-2</pub-id><pub-id pub-id-type="pmid">12721813</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>W.
                            G.</given-names></name><name><surname>Mash</surname><given-names>D.
                                C.</given-names></name></person-group> (<year>2009</year>).
                        <article-title>Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause
                        of ALS and other neurodegenerative diseases</article-title>.
                        <source/>Amyotroph. Lateral Scler.
                    <volume>10</volume>, <fpage>7</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.3109/17482960903286009</pub-id><pub-id pub-id-type="pmid">19929726</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>L.
                            E.</given-names></name><name><surname>Pablo</surname><given-names>J.</given-names></name><name><surname>Compton</surname><given-names>A.</given-names></name><name><surname>Hammerschlag</surname><given-names>N.</given-names></name><name><surname>Mash</surname><given-names>D.
                                C.</given-names></name></person-group> (<year>2010</year>).
                        <article-title>Cyanobacterial blooms and the occurrence of the neurotoxin,
                        β-N-methylamino-L-alanine (BMAA), in South Florida aquatic food
                        webs</article-title>. <source/>Harmful Algae
                    <volume>9</volume>, <fpage>620</fpage>–<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1016/j.hal.2010.05.002</pub-id><pub-id pub-id-type="pmid">21057660</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bras</surname><given-names>J.
                            M.</given-names></name><name><surname>Singleton</surname><given-names>A.</given-names></name></person-group>
                        (<year>2009</year>). <article-title>Genetic susceptibility in
                        Parkinson’s disease</article-title>. <source/>Biochim. Biophys.
                        Acta
                    <volume>1792</volume>, <fpage>597</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2008.11.008</pub-id><pub-id pub-id-type="pmid">19063963</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>J.
                            S.</given-names></name><name><surname>Hoffmann</surname><given-names>O.</given-names></name><name><surname>Schickhaus</surname><given-names>M.</given-names></name><name><surname>Freyer</surname><given-names>D.</given-names></name><name><surname>Dagand</surname><given-names>E.</given-names></name><name><surname>Bermpohl</surname><given-names>D.</given-names></name><etal></etal></person-group>.
                        (<year>2007</year>). <article-title>Pneumolysin causes neuronal cell death
                        through mitochondrial damage</article-title>. <source/>Infect.
                        Immun.
                    <volume>75</volume>, <fpage>4245</fpage>–<lpage>4254</lpage>. <pub-id pub-id-type="doi">10.1128/iai.00031-07</pub-id><pub-id pub-id-type="pmid">17562768</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>S.</given-names></name></person-group>
                        (<year>2013</year>). <article-title>Blue-green algae or cyanobacteria in the
                        intestinal micro-flora may produce neurotoxins such as
                        β-N-Methylamino-L-Alanine (BMAA) which may be related to development
                        of amyotrophic lateral sclerosis, Alzheimer’s disease and
                        Parkinson-Dementia-Complex in humans and equine motor neuron disease in
                        horses</article-title>. <source/>Med. Hypotheses
                    <volume>80</volume>:<fpage>103</fpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2012.10.010</pub-id><pub-id pub-id-type="pmid">23146671</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>E.
                            D.</given-names></name><name><surname>Stevenson</surname><given-names>D.
                                W.</given-names></name><name><surname>McCombie</surname><given-names>R.
                                W.</given-names></name><name><surname>Katari</surname><given-names>M.
                                S.</given-names></name><name><surname>Rudd</surname><given-names>S.
                                A.</given-names></name><name><surname>Mayer</surname><given-names>K.
                                F. X.</given-names></name><etal></etal></person-group>.
                    (<year>2003</year>). <article-title>Expressed sequence tag analysis in Cycas,
                        the most primitive living seed plant</article-title>. <source/>Genome
                        Biol.
                    <volume>4</volume>:<fpage>R78</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2003-4-12-r78</pub-id><pub-id pub-id-type="pmid">14659015</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bullwinkle</surname><given-names>T.</given-names></name><name><surname>Lazazzera</surname><given-names>B.</given-names></name><name><surname>Ibba</surname><given-names>M.</given-names></name></person-group>
                        (<year>2014</year>). <article-title>Quality control and infiltration of
                        translation by amino acids outside of the genetic code</article-title>.
                        <source/>Annu. Rev. Genet.
                    <volume>48</volume>, <fpage>149</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-120213-092101</pub-id><pub-id pub-id-type="pmid">25195507</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H.-Y.</given-names></name><name><surname>Tian</surname><given-names>K.-W.</given-names></name><name><surname>Zhang</surname><given-names>Y.-Y.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name></person-group>
                        (<year>2018</year>). <article-title>Angiopoietin-1 and αnuβ3
                        integrin peptide promote the therapeutic effects of L-serine in an
                        amyotrophic lateral sclerosis/Parkinsonism dementia complex
                        model</article-title>. <source/>Aging
                    <volume>10</volume>, <fpage>3507</fpage>–<lpage>3527</lpage>. <pub-id pub-id-type="doi">10.18632/aging.101661</pub-id><pub-id pub-id-type="pmid">30476904</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>S.
                            M.</given-names></name><name><surname>Empadinhas</surname><given-names>N.</given-names></name></person-group>
                        (<year>2018</year>). <article-title>The microbiome-mitochondria dance in
                        prodromal Parkinson’s disease</article-title>. <source/>Front.
                        Physiol.
                    <volume>9</volume>:<fpage>471</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2018.00471</pub-id><pub-id pub-id-type="pmid">29867531</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>S.</given-names></name><name><surname>Moreira</surname><given-names>P.</given-names></name><name><surname>Agostinho</surname><given-names>P.</given-names></name><name><surname>Pereira</surname><given-names>C.</given-names></name><name><surname>Oliveira</surname><given-names>C.</given-names></name></person-group>
                        (<year>2005</year>). <article-title>Neurodegenerative pathways in
                        Parkinson’s disease: therapeutic strategies</article-title>.
                        <source/>Curr. Drug Targets CNS Neurol. Disord.
                    <volume>4</volume>, <fpage>405</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.2174/1568007054546072</pub-id><pub-id pub-id-type="pmid">16101557</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cersosimo</surname><given-names>M.
                            G.</given-names></name></person-group> (<year>2015</year>).
                        <article-title>Gastrointestinal biopsies for the diagnosis of
                        α-synuclein pathology in Parkinson’s
                    disease</article-title>. <source/>Gastroenterol. Res. Pract.
                    <volume>2015</volume>:<fpage>476041</fpage>. <pub-id pub-id-type="doi">10.1155/2015/476041</pub-id><pub-id pub-id-type="pmid">26078752</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cersosimo</surname><given-names>M.
                            G.</given-names></name><name><surname>Benarroch</surname><given-names>E.
                                E.</given-names></name></person-group> (<year>2012</year>).
                        <article-title>Pathological correlates of gastrointestinal dysfunction in
                        Parkinson’s disease</article-title>. <source/>Neurobiol.
                        Dis.
                    <volume>46</volume>, <fpage>559</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2011.10.014</pub-id><pub-id pub-id-type="pmid">22048068</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claesson</surname><given-names>M.
                            J.</given-names></name><name><surname>Jeffery</surname><given-names>I.
                                B.</given-names></name><name><surname>Conde</surname><given-names>S.</given-names></name><name><surname>Power</surname><given-names>S.
                                E.</given-names></name><name><surname>O’Connor</surname><given-names>E.
                                M.</given-names></name><name><surname>Cusack</surname><given-names>S.</given-names></name><etal></etal></person-group>.
                        (<year>2012</year>). <article-title>Gut microbiota composition correlates
                        with diet and health in the elderly</article-title>. <source/>Nature
                    <volume>488</volume>, <fpage>178</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/nature11319</pub-id><pub-id pub-id-type="pmid">22797518</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>S.
                            M.</given-names></name><name><surname>Surette</surname><given-names>M.</given-names></name><name><surname>Bercik</surname><given-names>P.</given-names></name></person-group>
                        (<year>2012</year>). <article-title>The interplay between the intestinal
                        microbiota and the brain</article-title>. <source/>Nat. Rev.
                        Microbiol.
                    <volume>10</volume>, <fpage>735</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2876</pub-id><pub-id pub-id-type="pmid">23000955</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Combes</surname><given-names>A.</given-names></name><name><surname>El
                                Abdellaoui</surname><given-names>S.</given-names></name><name><surname>Sarazin</surname><given-names>C.</given-names></name><name><surname>Vial</surname><given-names>J.</given-names></name><name><surname>Mejean</surname><given-names>A.</given-names></name><name><surname>Ploux</surname><given-names>O.</given-names></name><etal></etal></person-group>.
                        (<year>2013</year>). <article-title>Validation of the analytical procedure
                        for the determination of the neurotoxin β-N-methylamino-L-alanine in
                        complex environmental samples</article-title>. <source/>Anal. Chim.
                        Acta
                    <volume>771</volume>, <fpage>42</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2013.02.016</pub-id><pub-id pub-id-type="pmid">23522111</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contardo-Jara</surname><given-names>V.</given-names></name><name><surname>Schwanemann</surname><given-names>T.</given-names></name><name><surname>Esterhuizen-Londt</surname><given-names>M.</given-names></name><name><surname>Pflugmacher</surname><given-names>S.</given-names></name></person-group>
                        (<year>2018</year>). <article-title>Protein association of
                        β-N-methylamino-L-alanine in Triticum aestivum <italic>via</italic>
                        irrigation irrigation</article-title>. <source/>Food Addit. Contam. Part A
                        Chem. Anal. Control Expo. Risk Assess.
                    <volume>35</volume>, <fpage>732</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1080/19440049.2018.1427283</pub-id><pub-id pub-id-type="pmid">29324084</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contardo-Jara</surname><given-names>V.</given-names></name><name><surname>Schwanemann</surname><given-names>T.</given-names></name><name><surname>Pflugmacher</surname><given-names>S.</given-names></name></person-group>
                        (<year>2014</year>). <article-title>Uptake of a cyanotoxin,
                        β-N-methylamino-L-alanine, by wheat (<italic>Triticum
                            aestivum</italic>)</article-title>. <source/>Ecotoxicol. Environ.
                        Saf.
                    <volume>104</volume>, <fpage>127</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2014.01.039</pub-id><pub-id pub-id-type="pmid">24675440</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>P.
                                A.</given-names></name><name><surname>Davis</surname><given-names>D.
                                A.</given-names></name><name><surname>Mash</surname><given-names>D.
                                C.</given-names></name><name><surname>Metcalf</surname><given-names>J.
                                S.</given-names></name><name><surname>Banack</surname><given-names>S.
                                A.</given-names></name></person-group> (<year>2016</year>).
                        <article-title>Dietary exposure to an environmental toxin triggers
                        neurofibrillary tangles and amyloid deposits in the brain</article-title>.
                        <source/>Proc. R. Soc.
                    <volume>283</volume>:<fpage>20152397</fpage>. <pub-id pub-id-type="doi">10.1098/rspb.2015.2397</pub-id><pub-id pub-id-type="pmid">26791617</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cryan</surname><given-names>J.
                            F.</given-names></name><name><surname>Dinan</surname><given-names>T.
                                G.</given-names></name></person-group> (<year>2012</year>).
                        <article-title>Mind-altering microorganisms: the impact of the gut
                        microbiota on brain and behaviour</article-title>. <source/>Nat. Rev.
                        Neurosci.
                    <volume>13</volume>, <fpage>701</fpage>–<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3346</pub-id><pub-id pub-id-type="pmid">22968153</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>R.</given-names><suffix>Jr.</suffix></name><name><surname>Marschall</surname><given-names>E.
                                G.</given-names></name><name><surname>Chan</surname><given-names>K.
                                C.</given-names></name><name><surname>Millard</surname><given-names>W.
                                J.</given-names></name><name><surname>Eppler</surname><given-names>B.</given-names></name><name><surname>Patterson</surname><given-names>T.
                                A.</given-names></name></person-group> (<year>1998</year>).
                        <article-title>Neurochemical and neurobehavioral effects of neonatal
                        administration of β-N-methylamino-L-alanine and
                        3,3’-iminodipropionitrile</article-title>. <source/>Neurotoxicol.
                        Teratol.
                    <volume>20</volume>, <fpage>181</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/s0892-0362(97)00078-0</pub-id><pub-id pub-id-type="pmid">9536463</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de
                            Munck</surname><given-names>E.</given-names></name><name><surname>Muñoz-Sáez</surname><given-names>E.</given-names></name><name><surname>Miguel</surname><given-names>B.
                                G.</given-names></name><name><surname>Solas</surname><given-names>M.
                                T.</given-names></name><name><surname>Ojeda</surname><given-names>I.</given-names></name><name><surname>Martínez</surname><given-names>A.</given-names></name><etal></etal></person-group>.
                        (<year>2013</year>). <article-title>β-N-methylamino-L-alanine causes
                        neurological and pathological phenotypes mimicking Amyotrophic Lateral
                        Sclerosis (ALS): the first step towards an experimental model for sporadic
                        ALS</article-title>. <source/>Environ. Toxicol. Pharmacol.
                    <volume>36</volume>, <fpage>243</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1016/j.etap.2013.04.007</pub-id><pub-id pub-id-type="pmid">23688553</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delcourt</surname><given-names>N.</given-names></name><name><surname>Claudepierre</surname><given-names>T.</given-names></name><name><surname>Maignien</surname><given-names>T.</given-names></name><name><surname>Arnich</surname><given-names>N.</given-names></name><name><surname>Mattei</surname><given-names>C.</given-names></name></person-group>
                        (<year>2018</year>). <article-title>Cellular and molecular aspects of the
                        β-N-methylamino-L-alanine (BMAA) mode of action within the
                        neurodegenerative pathway: facts and controversy</article-title>.
                        <source/>Toxins
                    <volume>10</volume>:<fpage>E6</fpage>. <pub-id pub-id-type="doi">10.3390/toxins10010006</pub-id><pub-id pub-id-type="pmid">29271898</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Rienzi</surname><given-names>S.
                            C.</given-names></name><name><surname>Sharon</surname><given-names>I.</given-names></name><name><surname>Wrighton</surname><given-names>K.
                                C.</given-names></name><name><surname>Koren</surname><given-names>O.</given-names></name><name><surname>Hug</surname><given-names>L.
                                A.</given-names></name><name><surname>Thomas</surname><given-names>B.
                                C.</given-names></name><etal></etal></person-group>. (<year>2013</year>).
                        <article-title>The human gut and groundwater harbor non-photosynthetic
                        bacteria belonging to a new candidate phylum sibling to
                        Cyanobacteria</article-title>. <source/>Elife
                    <volume>2</volume>:<fpage>e01102</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.01102</pub-id><pub-id pub-id-type="pmid">24137540</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downing</surname><given-names>S.</given-names></name><name><surname>Banack</surname><given-names>S.
                                A.</given-names></name><name><surname>Metcalf</surname><given-names>J.
                                S.</given-names></name><name><surname>Cox</surname><given-names>P.
                                A.</given-names></name><name><surname>Downing</surname><given-names>T.
                                G.</given-names></name></person-group> (<year>2011</year>).
                        <article-title>Nitrogen starvation of cyanobacteria results in the
                        production of β-N-methylamino-L-alanine</article-title>.
                        <source/>Toxicon
                    <volume>58</volume>, <fpage>187</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2011.05.017</pub-id><pub-id pub-id-type="pmid">21704054</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downing</surname><given-names>S.</given-names></name><name><surname>Downing</surname><given-names>T.
                                G.</given-names></name></person-group> (<year>2016</year>).
                        <article-title>The metabolism of the non-proteinogenic amino acid
                        β-N-methylamino-L-alanine (BMAA) in the cyanobacterium Synechocystis
                        PCC6803</article-title>. <source/>Toxicon
                    <volume>115</volume>, <fpage>41</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2016.03.005</pub-id><pub-id pub-id-type="pmid">26948425</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downing</surname><given-names>S.</given-names></name><name><surname>Van
                                Onselen</surname><given-names>R.</given-names></name><name><surname>Kemp</surname><given-names>G.</given-names></name><name><surname>Downing</surname><given-names>T.
                                G.</given-names></name></person-group> (<year>2019</year>).
                        <article-title>Metabolism of the neurotoxic amino acid
                        β-N-methylamino-L-alanine in human cell culture
                        models</article-title>. <source/>Toxicon
                    <volume>168</volume>, <fpage>131</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2019.07.007</pub-id><pub-id pub-id-type="pmid">31330193</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>R.
                            A.</given-names></name><name><surname>Cox</surname><given-names>P.
                                A.</given-names></name><name><surname>Banack</surname><given-names>S.
                                A.</given-names></name><name><surname>Rodgers</surname><given-names>K.
                                J.</given-names></name></person-group> (<year>2013</year>).
                        <article-title>The non-protein amino acid BMAA Is misincorporated into human
                        proteins in place of L-serine causing protein misfolding and
                        aggregation</article-title>. <source/>PLoS One
                    <volume>8</volume>:<fpage>e75376</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0075376</pub-id><pub-id pub-id-type="pmid">24086518</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>R.
                            A.</given-names></name><name><surname>Guillemin</surname><given-names>G.
                                J.</given-names></name></person-group> (<year>2019</year>).
                        <article-title>The cyanotoxin and non-protein amino acid
                        β-methylamino-L-alanine (L-BMAA) in the food chain: incorporation
                        into proteins and its impact on human health</article-title>.
                        <source/>Neurotox. Res.
                    <volume>36</volume>, <fpage>602</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-019-00089-9</pub-id><pub-id pub-id-type="pmid">31377995</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esterhuizen-Londt</surname><given-names>M.</given-names></name><name><surname>Pflugmacher</surname><given-names>S.</given-names></name></person-group>
                        (<year>2019</year>). <article-title>Vegetables cultivated with exposure to
                        pure and naturally occurring β-N-methylamino-L-alanine (BMAA)
                            <italic>via</italic> irrigation</article-title>. <source/>Environ.
                        Res.
                    <volume>169</volume>, <fpage>357</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1016/j.envres.2018.11.030</pub-id><pub-id pub-id-type="pmid">30508701</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faassen</surname><given-names>E.
                            J.</given-names></name></person-group> (<year>2014</year>).
                        <article-title>Presence of the neurotoxin BMAA in aquatic ecosystems: what
                        do we really know?</article-title>
<source/>Toxins
                    <volume>6</volume>, <fpage>1109</fpage>–<lpage>1138</lpage>. <pub-id pub-id-type="doi">10.3390/toxins6031109</pub-id><pub-id pub-id-type="pmid">24662480</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>S.
                            M.</given-names></name><name><surname>Molitoris</surname><given-names>D.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Vaisanen</surname><given-names>M.</given-names></name><name><surname>Bolte</surname><given-names>E.</given-names></name><etal></etal></person-group>.
                        (<year>2002</year>). <article-title>Gastrointestinal microflora studies in
                        late-onset autism</article-title>. <source/>Clin. Infect. Dis.
                    <volume>35</volume>, <fpage>S6</fpage>–<lpage>S16</lpage>. <pub-id pub-id-type="doi">10.1086/341914</pub-id><pub-id pub-id-type="pmid">12173102</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>P.</given-names></name><name><surname>Bienenstock</surname><given-names>J.</given-names></name><name><surname>Kunze</surname><given-names>W.
                                A.</given-names></name></person-group> (<year>2014</year>).
                        “<article-title>Vagal pathways for microbiome-brain-gut axis
                        communication</article-title>,” in <source/>Microbial Endocrinology:
                        The Microbiota-Gut-Brain Axis in Health and Disease. Advances in
                        Experimental Medicine and Biology, vol 817, eds <person-group person-group-type="editor"><name><surname>Lyte</surname><given-names>M.</given-names></name><name><surname>Cryan</surname><given-names>J.</given-names></name></person-group>
                        (<publisher-loc>New York, NY</publisher-loc>:
                        <publisher-name>Springer</publisher-name>),
                        <fpage>115</fpage>–<lpage>133</lpage>.</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsyth</surname><given-names>C.
                            B.</given-names></name><name><surname>Shannon</surname><given-names>K.
                                M.</given-names></name><name><surname>Kordower</surname><given-names>J.
                                H.</given-names></name><name><surname>Voigt</surname><given-names>R.
                                M.</given-names></name><name><surname>Shaikh</surname><given-names>M.</given-names></name><name><surname>Jaglin</surname><given-names>J.
                                A.</given-names></name><etal></etal></person-group>. (<year>2011</year>).
                        <article-title>Increased intestinal permeability correlates with sigmoid
                        mucosa α-synuclein staining and endotoxin exposure markers in early
                        Parkinson’s disease</article-title>. <source/>PLoS One
                    <volume>6</volume>:<fpage>e28032</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028032</pub-id><pub-id pub-id-type="pmid">22145021</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>L.</given-names></name><name><surname>Cookson</surname><given-names>M.
                                R.</given-names></name><name><surname>Petrucelli</surname><given-names>L.</given-names></name><name><surname>La
                                Spada</surname><given-names>A.
                        R.</given-names></name></person-group> (<year>2018</year>).
                        <article-title>Converging pathways in neurodegeneration, from genetics to
                        mechanisms</article-title>. <source/>Nat. Neurosci.
                    <volume>21</volume>, <fpage>1300</fpage>–<lpage>1309</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0237-7</pub-id><pub-id pub-id-type="pmid">30258237</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garruto</surname><given-names>R.
                            M.</given-names></name><name><surname>Fukatsu</surname><given-names>R.</given-names></name><name><surname>Yanagihara</surname><given-names>R.</given-names></name><name><surname>Gajdusek</surname><given-names>D.
                                C.</given-names></name><name><surname>Hook</surname><given-names>G.</given-names></name><name><surname>Fiori</surname><given-names>C.
                                E.</given-names></name></person-group> (<year>1984</year>).
                        <article-title>Imaging of calcium and aluminum in neurofibrillary
                        tangle-bearing neurons in parkinsonism-dementia of Guam</article-title>.
                        <source/>Proc. Natl. Acad. Sci. U S A
                    <volume>81</volume>, <fpage>1875</fpage>–<lpage>1879</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.81.6.1875</pub-id><pub-id pub-id-type="pmid">6584922</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gershon</surname><given-names>M.
                            D.</given-names></name></person-group> (<year>1999</year>).
                        <article-title>The enteric nervous system: a second brain</article-title>.
                        <source/>Hosp. Pract.
                    <volume>34</volume>, <fpage>31</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.3810/hp.1999.07.153</pub-id><pub-id pub-id-type="pmid">10418549</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname><given-names>W.
                            B.</given-names></name><name><surname>Mash</surname><given-names>D.
                                C.</given-names></name><name><surname>Murch</surname><given-names>S.
                                J.</given-names></name></person-group> (<year>2014</year>).
                        <article-title>The natural non-protein amino acid
                        N-β-methylamino-L-alanine (BMAA) is incorporated into protein during
                        synthesis</article-title>. <source/>Amino Acids
                    <volume>46</volume>, <fpage>2553</fpage>–<lpage>2559</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-014-1812-1</pub-id><pub-id pub-id-type="pmid">25096519</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grazioli</surname><given-names>S.</given-names></name><name><surname>Pugin</surname><given-names>J.</given-names></name></person-group>
                        (<year>2018</year>). <article-title>Mitochondrial damage-associated
                        molecular patterns: from inflammatory signaling to human
                        diseases</article-title>. <source/>Front. Immunol.
                    <volume>9</volume>:<fpage>832</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00832</pub-id><pub-id pub-id-type="pmid">29780380</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hata</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>N.</given-names></name><name><surname>Yoneda</surname><given-names>M.</given-names></name><name><surname>Morimoto</surname><given-names>S.</given-names></name><name><surname>Okano</surname><given-names>H.</given-names></name><name><surname>Murayama</surname><given-names>S.</given-names></name><etal></etal></person-group>.
                        (<year>2018</year>). <article-title>Nitrative stress and tau accumulation in
                        amyotrophic lateral sclerosis/Parkinsonism-dementia complex (ALS/PDC) in the
                        kii peninsula, japan</article-title>. <source/>Front. Neurosci.
                    <volume>11</volume>:<fpage>751</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2017.00751</pub-id><pub-id pub-id-type="pmid">29403345</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkes</surname><given-names>C.
                            H.</given-names></name><name><surname>Del
                                Tredici</surname><given-names>K.</given-names></name><name><surname>Braak</surname><given-names>H.</given-names></name></person-group>
                        (<year>2007</year>). <article-title>Parkinson’s disease: a dual-hit
                        hypothesis</article-title>. <source/>Neuropathol. Appl. Neurobiol.
                    <volume>33</volume>, <fpage>599</fpage>–<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2007.00874.x</pub-id><pub-id pub-id-type="pmid">17961138</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hibbing</surname><given-names>M.
                            E.</given-names></name><name><surname>Fuqua</surname><given-names>C.</given-names></name><name><surname>Parsek</surname><given-names>M.
                                R.</given-names></name><name><surname>Peterson</surname><given-names>S.
                                B.</given-names></name></person-group> (<year>2010</year>).
                        <article-title>Bacterial competition: surviving and thriving in the
                        microbial jungle</article-title>. <source/>Nat. Rev. Microbiol.
                    <volume>8</volume>, <fpage>15</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2259</pub-id><pub-id pub-id-type="pmid">19946288</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hroudová</surname><given-names>J.</given-names></name><name><surname>Singh</surname><given-names>N.</given-names></name><name><surname>Fišar</surname><given-names>Z.</given-names></name></person-group>
                        (<year>2014</year>). <article-title>Mitochondrial dysfunctions in
                        neurodegenerative diseases: relevance to Alzheimer’s
                        disease</article-title>. <source/>Biomed. Res. Int.
                    <volume>2014</volume>:<fpage>175062</fpage>. <pub-id pub-id-type="doi">10.1155/2014/175062</pub-id><pub-id pub-id-type="pmid">24900954</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ince</surname><given-names>P.
                            G.</given-names></name><name><surname>Codd</surname><given-names>G.
                                A.</given-names></name></person-group> (<year>2005</year>).
                        <article-title>Return of the cycad hypothesis—does the amyotrophic
                        lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new
                        implications for global health?</article-title>
<source/>Neuropathol. Appl. Neurobiol.
                    <volume>31</volume>, <fpage>345</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2005.00686.x</pub-id><pub-id pub-id-type="pmid">16008818</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Eriksson</surname><given-names>J.</given-names></name><name><surname>Lage</surname><given-names>S.</given-names></name><name><surname>Jonasson</surname><given-names>S.</given-names></name><name><surname>Shams</surname><given-names>S.</given-names></name><name><surname>Mehine</surname><given-names>M.</given-names></name><etal></etal></person-group>.
                        (<year>2014</year>). <article-title>Diatoms: a novel source for the
                        neurotoxin BMAA in aquatic environments</article-title>. <source/>PLoS
                        One
                    <volume>9</volume>:<fpage>e84578</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0084578</pub-id><pub-id pub-id-type="pmid">24392143</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Johnston</surname><given-names>E.</given-names></name><name><surname>Åberg</surname><given-names>K.
                                M.</given-names></name><name><surname>Nilsson</surname><given-names>U.</given-names></name><name><surname>Ilag</surname><given-names>L.
                                L.</given-names></name></person-group> (<year>2013</year>).
                        <article-title>Strategy for quantifying trace levels of BMAA in
                        cyanobacteria by LC/MS/MS</article-title>. <source/>Anal. Bioanal.
                        Chem.
                    <volume>405</volume>, <fpage>1283</fpage>–<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-012-6550-1</pub-id><pub-id pub-id-type="pmid">23180086</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johri</surname><given-names>A.</given-names></name><name><surname>Beal</surname><given-names>M.
                                F.</given-names></name></person-group> (<year>2012</year>).
                        <article-title>Mitochondrial dysfunction in neurodegenerative
                        diseases</article-title>. <source/>J. Pharmacol. Exp. Ther.
                    <volume>342</volume>, <fpage>619</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.112.192138</pub-id><pub-id pub-id-type="pmid">22700435</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonasson</surname><given-names>S.</given-names></name><name><surname>Eriksson</surname><given-names>J.</given-names></name><name><surname>Berntzon</surname><given-names>L.</given-names></name><name><surname>Spácil</surname><given-names>Z.</given-names></name><name><surname>Ilag</surname><given-names>L.
                                L.</given-names></name><name><surname>Ronnevi</surname><given-names>L.-O.</given-names></name><etal></etal></person-group>.
                        (<year>2010</year>). <article-title>Transfer of a cyanobacterial neurotoxin
                        within a temperate aquatic ecosystem suggests pathways for human
                        exposure</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
                    <volume>107</volume>, <fpage>9252</fpage>–<lpage>9257</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914417107</pub-id><pub-id pub-id-type="pmid">20439734</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Kwon</surname><given-names>S.-H.</given-names></name><name><surname>Kam</surname><given-names>T.-I.</given-names></name><name><surname>Panicker</surname><given-names>N.</given-names></name><name><surname>Karuppagounder</surname><given-names>S.
                                S.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><etal></etal></person-group>.
                        (<year>2019</year>). <article-title>Transneuronal propagation of pathologic
                        α-synuclein from the gut to the brain models Parkinson’s
                        disease</article-title>. <source/>Neuron
                    <volume>103</volume>, <fpage>627.e7</fpage>–<lpage>641.e7</lpage>.
                        <pub-id pub-id-type="doi">10.1016/j.neuron.2019.05.035</pub-id><pub-id pub-id-type="pmid">31255487</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lage</surname><given-names>S.</given-names></name><name><surname>Burian</surname><given-names>A.</given-names></name><name><surname>Rasmussen</surname><given-names>U.</given-names></name><name><surname>Costa</surname><given-names>P.
                                R.</given-names></name><name><surname>Annadotter</surname><given-names>H.</given-names></name><name><surname>Godhe</surname><given-names>A.</given-names></name><etal></etal></person-group>.
                        (<year>2016a</year>). <article-title>BMAA extraction of cyanobacteria
                        samples: which method to choose?</article-title>
<source/>Environ. Sci. Pollut. Res.
                    <volume>23</volume>, <fpage>338</fpage>–<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1007/s11356-015-5266-0</pub-id><pub-id pub-id-type="pmid">26304815</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lage</surname><given-names>S.</given-names></name><name><surname>Ström</surname><given-names>L.</given-names></name><name><surname>Godhe</surname><given-names>A.</given-names></name><name><surname>Rydberg</surname><given-names>S.</given-names></name></person-group>
                        (<year>2016b</year>). <article-title>The effect of exogenous
                        β-N-methylamino-L-alanine (BMAA) on the diatoms Phaeodactylum
                        tricornutum and Thalassiosira weissflogii</article-title>. <source/>Harmful
                        Algae
                    <volume>58</volume>, <fpage>85</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.hal.2016.08.005</pub-id><pub-id pub-id-type="pmid">28073463</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lage</surname><given-names>S.</given-names></name><name><surname>Costa</surname><given-names>P.
                                R.</given-names></name><name><surname>Moita</surname><given-names>T.</given-names></name><name><surname>Eriksson</surname><given-names>J.</given-names></name><name><surname>Rasmussen</surname><given-names>U.</given-names></name><name><surname>Rydberg</surname><given-names>S.
                                J.</given-names></name></person-group> (<year>2014</year>).
                        <article-title>BMAA in shellfish from two Portuguese transitional water
                        bodies suggests the marine dinoflagellate Gymnodinium catenatum as a
                        potential BMAA source</article-title>. <source/>Aquat. Toxicol.
                    <volume>152</volume>, <fpage>131</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.aquatox.2014.03.029</pub-id><pub-id pub-id-type="pmid">24747603</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lance</surname><given-names>E.</given-names></name><name><surname>Arnich</surname><given-names>N.</given-names></name><name><surname>Maignien</surname><given-names>T.</given-names></name><name><surname>Biré</surname><given-names>R.</given-names></name></person-group>
                        (<year>2018</year>). <article-title>Occurrence of
                        β-N-methylamino-L-alanine (BMAA) and isomers in aquatic environments
                        and aquatic food sources for humans</article-title>. <source/>Toxins
                    <volume>10</volume>:<fpage>E191</fpage>. <pub-id pub-id-type="doi">10.3390/toxins10050191</pub-id><pub-id pub-id-type="pmid">29748472</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebouvier</surname><given-names>T.</given-names></name><name><surname>Chaumette</surname><given-names>T.</given-names></name><name><surname>Paillusson</surname><given-names>S.</given-names></name><name><surname>Duyckaerts</surname><given-names>C.</given-names></name><name><surname>Bruley
                                des
                                Varannes</surname><given-names>S.</given-names></name><name><surname>Neunlist</surname><given-names>M.</given-names></name><etal></etal></person-group>.
                        (<year>2009</year>). <article-title>The second brain and Parkinson’s
                        disease</article-title>. <source/>Eur. J. Neurosci.
                    <volume>30</volume>, <fpage>735</fpage>–<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.06873.x</pub-id><pub-id pub-id-type="pmid">19712093</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.
                                W.</given-names></name><name><surname>Beebe</surname><given-names>K.</given-names></name><name><surname>Nangle</surname><given-names>L.
                                A.</given-names></name><name><surname>Jang</surname><given-names>J.</given-names></name><name><surname>Longo-Guess</surname><given-names>C.
                                M.</given-names></name><name><surname>Cook</surname><given-names>S.
                                A.</given-names></name><etal></etal></person-group>. (<year>2006</year>).
                        <article-title>Editing-defective tRNA synthetase causes protein misfolding
                        and neurodegeneration</article-title>. <source/>Nature
                    <volume>443</volume>, <fpage>50</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/nature05096</pub-id><pub-id pub-id-type="pmid">16906134</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W.-J.</given-names></name><name><surname>Hase</surname><given-names>K.</given-names></name></person-group>
                        (<year>2014</year>). <article-title>Gut microbiota-generated metabolites in
                        animal health and disease</article-title>. <source/>Nat. Chem. Biol.
                    <volume>10</volume>, <fpage>416</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1535</pub-id><pub-id pub-id-type="pmid">24838170</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ley</surname><given-names>R.
                                E.</given-names></name><name><surname>Peterson</surname><given-names>D.
                                A.</given-names></name><name><surname>Gordon</surname><given-names>J.
                                I.</given-names></name></person-group> (<year>2006</year>).
                        <article-title>Ecological and evolutionary forces shaping microbial
                        diversity in the human intestine</article-title>. <source/>Cell
                    <volume>124</volume>, <fpage>837</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.02.017</pub-id><pub-id pub-id-type="pmid">16497592</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>R.</given-names></name><name><surname>Banack</surname><given-names>S.
                                A.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group>
                        (<year>2010</year>). <article-title>Detection of the neurotoxin BMAA within
                        cyanobacteria isolated from freshwater in China</article-title>.
                        <source/>Toxicon
                    <volume>55</volume>, <fpage>947</fpage>–<lpage>953</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2009.09.023</pub-id><pub-id pub-id-type="pmid">19822166</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Main</surname><given-names>B.
                            J.</given-names></name><name><surname>Dunlop</surname><given-names>R.
                                A.</given-names></name><name><surname>Rodgers</surname><given-names>K.
                                J.</given-names></name></person-group> (<year>2016</year>).
                        <article-title>The use of L-serine to prevent
                        β-methylamino-L-alanine (BMAA)-induced proteotoxic stress <italic>in
                            vitro</italic></article-title>. <source/>Toxicon
                    <volume>109</volume>, <fpage>7</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2015.11.003</pub-id><pub-id pub-id-type="pmid">26559613</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>J.
                            B.</given-names></name></person-group> (<year>1999</year>).
                        <article-title>Molecular basis of the neurodegenerative
                        disorders</article-title>. <source/>N. Engl. J. Med.
                    <volume>340</volume>, <fpage>1970</fpage>–<lpage>1980</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199906243402507</pub-id><pub-id pub-id-type="pmid">10379022</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>E.
                            A.</given-names></name></person-group> (<year>2011</year>).
                        <article-title>Gut feelings: the emerging biology of gut-brain
                        communication</article-title>. <source/>Nat. Rev. Neurosci.
                    <volume>12</volume>, <fpage>453</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3071</pub-id><pub-id pub-id-type="pmid">21750565</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarland</surname><given-names>N.
                            R.</given-names></name><name><surname>Fan</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Schwarzschild</surname><given-names>M.
                                A.</given-names></name><name><surname>Feany</surname><given-names>M.
                                B.</given-names></name><name><surname>Hyman</surname><given-names>B.
                                T.</given-names></name><etal></etal></person-group>. (<year>2009</year>).
                        <article-title>α-synuclein S129 phosphorylation mutants do not alter
                        nigrostriatal toxicity in a rat model of parkinson disease</article-title>.
                        <source/>J. Neuropathol. Exp. Neurol.
                    <volume>68</volume>, <fpage>515</fpage>–<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e3181a24b53</pub-id><pub-id pub-id-type="pmid">19525899</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McVey Neufeld</surname><given-names>K.
                                A.</given-names></name><name><surname>Mao</surname><given-names>Y.
                                K.</given-names></name><name><surname>Bienenstock</surname><given-names>J.</given-names></name><name><surname>Foster</surname><given-names>J.
                                A.</given-names></name><name><surname>Kunze</surname><given-names>W.
                                A.</given-names></name></person-group> (<year>2013</year>).
                        <article-title>The microbiome is essential for normal gut intrinsic primary
                        afferent neuron excitability in the mouse</article-title>.
                        <source/>Neurogastroenterol. Motil.
                    <volume>25</volume>, <fpage>183</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1111/nmo.12049</pub-id><pub-id pub-id-type="pmid">23181420</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meneely</surname><given-names>J.
                            P.</given-names></name><name><surname>Chevallier</surname><given-names>O.
                                P.</given-names></name><name><surname>Graham</surname><given-names>S.</given-names></name><name><surname>Greer</surname><given-names>B.</given-names></name><name><surname>Green</surname><given-names>B.
                                D.</given-names></name><name><surname>Elliott</surname><given-names>C.
                                T.</given-names></name></person-group> (<year>2016</year>).
                        <article-title>β-methylamino-L-alanine (BMAA) is not found in the
                        brains of patients with confirmed Alzheimer’s
                        disease</article-title>. <source/>Sci. Rep.
                    <volume>6</volume>:<fpage>36363</fpage>. <pub-id pub-id-type="doi">10.1038/srep36363</pub-id><pub-id pub-id-type="pmid">27821863</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metcalf</surname><given-names>J.
                            S.</given-names></name><name><surname>Lobner</surname><given-names>D.</given-names></name><name><surname>Banack</surname><given-names>S.
                                A.</given-names></name><name><surname>Cox</surname><given-names>G.
                                A.</given-names></name><name><surname>Nunn</surname><given-names>P.
                                B.</given-names></name><name><surname>Wyatt</surname><given-names>P.
                                B.</given-names></name><etal></etal></person-group>. (<year>2017</year>).
                        <article-title>Analysis of BMAA enantiomers in cycads, cyanobacteria, and
                        mammals: <italic>in vivo</italic> formation and toxicity of
                        D-BMAA</article-title>. <source/>Amino Acids
                    <volume>49</volume>, <fpage>1427</fpage>–<lpage>1439</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-017-2445-y</pub-id><pub-id pub-id-type="pmid">28620737</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelson</surname><given-names>N.</given-names></name><name><surname>Facciponte</surname><given-names>D.</given-names></name><name><surname>Bradley</surname><given-names>W.</given-names></name><name><surname>Stommel</surname><given-names>E.</given-names></name></person-group>
                        (<year>2017</year>). <article-title>Cytokine expression levels in ALS: a
                        potential link between inflammation and BMAA-triggered protein
                        misfolding</article-title>. <source/>Cytokine Growth Factor Rev.
                    <volume>37</volume>, <fpage>81</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2017.05.001</pub-id><pub-id pub-id-type="pmid">28532674</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>M.</given-names></name><name><surname>Moreira</surname><given-names>C.</given-names></name><name><surname>Vasconcelos</surname><given-names>V.
                                M.</given-names></name><name><surname>Baptista</surname><given-names>M.
                                S.</given-names></name></person-group> (<year>2017</year>).
                        <article-title>Screening of BMAA-producing cyanobacteria in cultured
                        isolates and in <italic>in situ</italic> blooms</article-title>. <source/>J.
                        Appl. Phycol.
                    <volume>29</volume>, <fpage>879</fpage>–<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1007/s10811-016-1003-4</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>S.</given-names></name><name><surname>Garcia-Gonzalez</surname><given-names>E.</given-names></name><name><surname>Mainz</surname><given-names>A.</given-names></name><name><surname>Hertlein</surname><given-names>G.</given-names></name><name><surname>Heid</surname><given-names>N.
                                C.</given-names></name><name><surname>Mösker</surname><given-names>E.</given-names></name><etal></etal></person-group>.
                        (<year>2014</year>). <article-title>Paenilamicin: structure and biosynthesis
                        of a hybrid nonribosomal peptide/polyketide antibiotic from the bee pathogen
                        paenibacillus larvae</article-title>. <source/>Angew. Chem. Int. Ed
                        Engl.
                    <volume>53</volume>, <fpage>10821</fpage>–<lpage>10825</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201404572</pub-id><pub-id pub-id-type="pmid">25080172</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muyderman</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name></person-group>
                        (<year>2014</year>). <article-title>Mitochondrial dysfunction in amyotrophic
                        lateral sclerosis—a valid pharmacological target?</article-title>
<source/>Br. J. Pharmacol.
                    <volume>171</volume>, <fpage>2191</fpage>–<lpage>2205</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12476</pub-id><pub-id pub-id-type="pmid">24148000</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagpal</surname><given-names>R.</given-names></name><name><surname>Mainali</surname><given-names>R.</given-names></name><name><surname>Ahmadi</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Kavanagh</surname><given-names>K.</given-names></name><etal></etal></person-group>.
                        (<year>2018</year>). <article-title>Gut microbiome and aging: physiological
                        and mechanistic insights</article-title>. <source/>Nutr. Healthy
                        Aging
                    <volume>4</volume>, <fpage>267</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.3233/nha-170030</pub-id><pub-id pub-id-type="pmid">29951588</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunn</surname><given-names>P.
                            B.</given-names></name><name><surname>Codd</surname><given-names>G.
                                A.</given-names></name></person-group> (<year>2017</year>).
                        <article-title>Metabolic solutions to the biosynthesis of some
                        diaminomonocarboxylic acids in nature: formation in cyanobacteria of the
                        neurotoxins 3-N-methyl-2,3-diaminopropanoic acid (BMAA) and
                        2,4-diaminobutanoic acid (2,4-DAB)</article-title>.
                        <source/>Phytochemistry
                    <volume>144</volume>, <fpage>253</fpage>–<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.phytochem.2017.09.015</pub-id><pub-id pub-id-type="pmid">29059579</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeso</surname><given-names>J.
                            A.</given-names></name><name><surname>Rodriguez-Oroz</surname><given-names>M.
                                C.</given-names></name><name><surname>Goetz</surname><given-names>C.
                                G.</given-names></name><name><surname>Marin</surname><given-names>C.</given-names></name><name><surname>Kordower</surname><given-names>J.
                                H.</given-names></name><name><surname>Rodriguez</surname><given-names>M.</given-names></name><etal></etal></person-group>.
                        (<year>2010</year>). <article-title>Missing pieces in the
                        Parkinson’s disease puzzle</article-title>. <source/>Nat.
                        Med.
                    <volume>16</volume>, <fpage>653</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2165</pub-id><pub-id pub-id-type="pmid">20495568</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onselen</surname><given-names>R.
                            van.</given-names></name><name><surname>Downing</surname><given-names>S.</given-names></name><name><surname>Kemp</surname><given-names>G.</given-names></name><name><surname>Downing</surname><given-names>T.</given-names></name></person-group>
                        (<year>2017</year>). <article-title>Investigating
                        β-N-methylamino-L-alanine misincorporation in human cell cultures: a
                        comparative study with known amino acid analogues</article-title>.
                        <source/>Toxins
                    <volume>9</volume>:<fpage>E400</fpage>. <pub-id pub-id-type="doi">10.3390/toxins9120400</pub-id><pub-id pub-id-type="pmid">29240689</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oueslati</surname><given-names>A.</given-names></name></person-group>
                        (<year>2016</year>). <article-title>Implication of α-synuclein
                        phosphorylation at S129 in synucleinopathies: what have we learned in the
                        last decade?</article-title>
<source/>J. Parkinsons Dis.
                    <volume>6</volume>, <fpage>39</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.3233/jpd-160779</pub-id><pub-id pub-id-type="pmid">27003784</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oueslati</surname><given-names>A.</given-names></name><name><surname>Paleologou</surname><given-names>K.
                                E.</given-names></name><name><surname>Schneider</surname><given-names>B.
                                L.</given-names></name><name><surname>Aebischer</surname><given-names>P.</given-names></name><name><surname>Lashuel</surname><given-names>H.
                                A.</given-names></name></person-group> (<year>2012</year>).
                        <article-title>Mimicking phosphorylation at serine 87 inhibits the
                        aggregation of human α-synuclein and protects against its toxicity
                        in a rat model of parkinson’s disease</article-title>. <source/>J.
                        Neurosci.
                    <volume>32</volume>, <fpage>1536</fpage>–<lpage>1544</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3784-11.2012</pub-id><pub-id pub-id-type="pmid">22302797</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parracho</surname><given-names>H. M. R.
                                T.</given-names></name><name><surname>Bingham</surname><given-names>M.
                                O.</given-names></name><name><surname>Gibson</surname><given-names>G.
                                R.</given-names></name><name><surname>McCartney</surname><given-names>A.
                                L.</given-names></name></person-group> (<year>2005</year>).
                        <article-title>Differences between the gut microflora of children with
                        autistic spectrum disorders and that of healthy children</article-title>.
                        <source/>J. Med. Microbiol.
                    <volume>54</volume>, <fpage>987</fpage>–<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.46101-0</pub-id><pub-id pub-id-type="pmid">16157555</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfeiffer</surname><given-names>R.
                            F.</given-names></name></person-group> (<year>2003</year>).
                        <article-title>Gastrointestinal dysfunction in Parkinson’s
                        disease</article-title>. <source/>Lancet Neurol.
                    <volume>2</volume>, <fpage>107</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(03)00307-7</pub-id><pub-id pub-id-type="pmid">12849267</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popova</surname><given-names>A.
                            A.</given-names></name><name><surname>Semashko</surname><given-names>T.
                                A.</given-names></name><name><surname>Kostina</surname><given-names>N.
                                V.</given-names></name><name><surname>Rasmussen</surname><given-names>U.</given-names></name><name><surname>Govorun</surname><given-names>V.
                                M.</given-names></name><name><surname>Koksharova</surname><given-names>O.
                                A.</given-names></name></person-group> (<year>2018</year>).
                        <article-title>The cyanotoxin BMAA induces heterocyst specific gene
                        expression in <italic>Anabaena</italic> sp. PCC 7120 under repressive
                        conditions</article-title>. <source/>Toxins
                    <volume>10</volume>:<fpage>E478</fpage>. <pub-id pub-id-type="doi">10.3390/toxins10110478</pub-id><pub-id pub-id-type="pmid">30453523</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>M.</given-names></name><name><surname>Gershon</surname><given-names>M.
                                D.</given-names></name></person-group> (<year>2016</year>).
                        <article-title>The bowel and beyond: the enteric nervous system in
                        neurological disorders</article-title>. <source/>Nat. Rev. Gastroenterol.
                        Hepatol.
                    <volume>13</volume>, <fpage>517</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2016.107</pub-id><pub-id pub-id-type="pmid">27435372</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichmann</surname><given-names>H.</given-names></name><name><surname>Schneider</surname><given-names>C.</given-names></name><name><surname>Löhle</surname><given-names>M.</given-names></name></person-group>
                        (<year>2009</year>). <article-title>Non-motor features of
                        Parkinson’s disease: depression and dementia</article-title>.
                        <source/>Parkinsonism Relat Disord.
                    <volume>15</volume>, <fpage>S87</fpage>–<lpage>S92</lpage>. <pub-id pub-id-type="doi">10.1016/S1353-8020(09)70789-8</pub-id><pub-id pub-id-type="pmid">20083017</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocchi</surname><given-names>A.</given-names></name><name><surname>Pellegrini</surname><given-names>S.</given-names></name><name><surname>Siciliano</surname><given-names>G.</given-names></name><name><surname>Murri</surname><given-names>L.</given-names></name></person-group>
                        (<year>2003</year>). <article-title>Causative and susceptibility genes for
                        Alzheimer’s disease: a review</article-title>. <source/>Brain Res.
                        Bull.
                    <volume>61</volume>, <fpage>1</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/s0361-9230(03)00067-4</pub-id><pub-id pub-id-type="pmid">12788204</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>K.
                            J.</given-names></name></person-group> (<year>2014</year>).
                        <article-title>Non-protein amino acids and neurodegeneration: the enemy
                        within</article-title>. <source/>Exp. Neurol.
                    <volume>253</volume>, <fpage>192</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2013.12.010</pub-id><pub-id pub-id-type="pmid">24374297</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>C.
                            A.</given-names></name><name><surname>Poirier</surname><given-names>M.
                                A.</given-names></name></person-group> (<year>2004</year>).
                        <article-title>Protein aggregation and neurodegenerative
                        disease</article-title>. <source/>Nat. Med.
                    <volume>10</volume>, <fpage>S10</fpage>–<lpage>S17</lpage>. <pub-id pub-id-type="doi">10.1038/nm1066</pub-id><pub-id pub-id-type="pmid">15272267</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saint-Georges-Chaumet</surname><given-names>Y.</given-names></name><name><surname>Edeas</surname><given-names>M.</given-names></name></person-group>
                        (<year>2016</year>). <article-title>Microbiota-mitochondria inter-talk:
                        consequence for microbiota-host interaction</article-title>. <source/>Pathog.
                        Dis.
                    <volume>74</volume>:<fpage>ftv096</fpage>. <pub-id pub-id-type="doi">10.1093/femspd/ftv096</pub-id><pub-id pub-id-type="pmid">26500226</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>T.
                            R.</given-names></name><name><surname>Debelius</surname><given-names>J.
                                W.</given-names></name><name><surname>Thron</surname><given-names>T.</given-names></name><name><surname>Janssen</surname><given-names>S.</given-names></name><name><surname>Shastri</surname><given-names>G.
                                G.</given-names></name><name><surname>Ilhan</surname><given-names>Z.
                                E.</given-names></name><etal></etal></person-group>. (<year>2016</year>).
                        <article-title>Gut microbiota regulate motor deficits and neuroinflammation
                        in a model of Parkinson’s disease</article-title>.
                        <source/>Cell
                    <volume>167</volume>, <fpage>1469.e12</fpage>–<lpage>1480.e12</lpage>.
                        <pub-id pub-id-type="doi">10.1016/j.cell.2016.11.018</pub-id><pub-id pub-id-type="pmid">27912057</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savica</surname><given-names>R.</given-names></name><name><surname>Carlin</surname><given-names>J.
                                M.</given-names></name><name><surname>Grossardt</surname><given-names>B.
                                R.</given-names></name><name><surname>Bower</surname><given-names>J.
                                H.</given-names></name><name><surname>Ahlskog</surname><given-names>J.
                                E.</given-names></name><name><surname>Maraganore</surname><given-names>D.
                                M.</given-names></name><etal></etal></person-group>. (<year>2009</year>).
                        <article-title>Medical records documentation of constipation preceding
                        Parkinson disease: a case-control study</article-title>.
                        <source/>Neurology
                    <volume>73</volume>, <fpage>1752</fpage>–<lpage>1758</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181c34af5</pub-id><pub-id pub-id-type="pmid">19933976</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekirov</surname><given-names>I.</given-names></name><name><surname>Russell</surname><given-names>S.</given-names></name><name><surname>Antunes</surname><given-names>L.</given-names></name><name><surname>Finlay</surname><given-names>B.
                                B.</given-names></name></person-group> (<year>2010</year>).
                        <article-title>Gut microbiota in health and disease</article-title>.
                        <source/>Physiol. Rev.
                    <volume>90</volume>, <fpage>859</fpage>–<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00045.2009</pub-id><pub-id pub-id-type="pmid">20664075</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>N.</given-names></name><name><surname>Kunisawa</surname><given-names>J.</given-names></name><name><surname>Kiyono</surname><given-names>H.</given-names></name></person-group>
                        (<year>2017</year>). <article-title>Dietary and microbial metabolites in the
                        regulation of host immunity</article-title>. <source/>Front.
                        Microbiol.
                    <volume>8</volume>:<fpage>2171</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.02171</pub-id><pub-id pub-id-type="pmid">29163449</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soo</surname><given-names>R.
                                M.</given-names></name><name><surname>Skennerton</surname><given-names>C.
                                T.</given-names></name><name><surname>Sekiguchi</surname><given-names>Y.</given-names></name><name><surname>Imelfort</surname><given-names>M.</given-names></name><name><surname>Paech</surname><given-names>S.
                                J.</given-names></name><name><surname>Dennis</surname><given-names>P.
                                G.</given-names></name><etal></etal></person-group>. (<year>2014</year>).
                        <article-title>An expanded genomic representation of the phylum
                        cyanobacteria</article-title>. <source/>Genome Biol. Evol.
                    <volume>6</volume>, <fpage>1031</fpage>–<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1093/gbe/evu073</pub-id><pub-id pub-id-type="pmid">24709563</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spáčil</surname><given-names>Z.</given-names></name><name><surname>Eriksson</surname><given-names>J.</given-names></name><name><surname>Jonasson</surname><given-names>S.</given-names></name><name><surname>Rasmussen</surname><given-names>U.</given-names></name><name><surname>Ilag</surname><given-names>L.
                                L.</given-names></name><name><surname>Bergman</surname><given-names>B.</given-names></name></person-group>
                        (<year>2010</year>). <article-title>Analytical protocol for identification
                        of BMAA and DAB in biological samples</article-title>.
                        <source/>Analyst
                    <volume>135</volume>, <fpage>127</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1039/b921048b</pub-id><pub-id pub-id-type="pmid">20024192</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stecher</surname><given-names>B.</given-names></name><name><surname>Hardt</surname><given-names>W.
                                D.</given-names></name></person-group> (<year>2008</year>).
                        <article-title>The role of microbiota in infectious disease</article-title>.
                        <source/>Trends Microbiol.
                    <volume>16</volume>, <fpage>107</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2007.12.008</pub-id><pub-id pub-id-type="pmid">18280160</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>J.</given-names></name><name><surname>Nutma</surname><given-names>E.</given-names></name><name><surname>van
                                der
                                Valk</surname><given-names>P.</given-names></name><name><surname>Amor</surname><given-names>S.</given-names></name></person-group>
                        (<year>2018</year>). <article-title>Inflammation in CNS neurodegenerative
                        diseases</article-title>. <source/>Immunology
                    <volume>154</volume>, <fpage>204</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12922</pub-id><pub-id pub-id-type="pmid">29513402</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname><given-names>E.</given-names></name><name><surname>Horváth-Puhó</surname><given-names>E.</given-names></name><name><surname>Thomsen</surname><given-names>R.
                                W.</given-names></name><name><surname>Djurhuus</surname><given-names>J.
                                C.</given-names></name><name><surname>Pedersen</surname><given-names>L.</given-names></name><name><surname>Borghammer</surname><given-names>P.</given-names></name><etal></etal></person-group>.
                        (<year>2015</year>). <article-title>Vagotomy and subsequent risk of
                        Parkinson’s disease</article-title>. <source/>Ann. Neurol.
                    <volume>78</volume>, <fpage>522</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1002/ana.24448</pub-id><pub-id pub-id-type="pmid">26031848</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takser</surname><given-names>L.</given-names></name><name><surname>Benachour</surname><given-names>N.</given-names></name><name><surname>Husk</surname><given-names>B.</given-names></name><name><surname>Cabana</surname><given-names>H.</given-names></name><name><surname>Gris</surname><given-names>D.</given-names></name></person-group>
                        (<year>2016</year>). <article-title>Cyanotoxins at low doses induce
                        apoptosis and inflammatory effects in murine brain cells: potential
                        implications for neurodegenerative diseases</article-title>.
                        <source/>Toxicol. Rep.
                    <volume>3</volume>, <fpage>180</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxrep.2015.12.008</pub-id><pub-id pub-id-type="pmid">28959538</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Den
                            Berge</surname><given-names>N.</given-names></name><name><surname>Ferreira</surname><given-names>N.</given-names></name><name><surname>Gram</surname><given-names>H.</given-names></name><name><surname>Mikkelsen</surname><given-names>T.
                                W.</given-names></name><name><surname>Alstrup</surname><given-names>A.
                                K.
                                O.</given-names></name><name><surname>Casadei</surname><given-names>N.</given-names></name><etal></etal></person-group>.
                        (<year>2019</year>). <article-title>Evidence for bidirectional and
                        trans-synaptic parasympathetic and sympathetic propagation of
                        α-synuclein in rats</article-title>. <source/>Acta
                        Neuropathol.
                    <volume>138</volume>, <fpage>535</fpage>–<lpage>550</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-019-02040-w</pub-id><pub-id pub-id-type="pmid">31254094</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van
                            Onselen</surname><given-names>R.</given-names></name><name><surname>Downing</surname><given-names>T.
                                G.</given-names></name></person-group> (<year>2018</year>).
                        <article-title>BMAA-protein interactions: a possible new mechanism of
                        toxicity</article-title>. <source/>Toxicon
                    <volume>143</volume>, <fpage>74</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2018.01.011</pub-id><pub-id pub-id-type="pmid">29407452</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van
                            Onselen</surname><given-names>R.</given-names></name><name><surname>Downing</surname><given-names>T.
                                G.</given-names></name></person-group> (<year>2019</year>).
                        <article-title>β-N-methylamino-L-alanine inhibits human catalase
                        activity: possible implications for neurodegenerative disease
                        development</article-title>. <source/>Int. J. Toxicol.
                    <volume>38</volume>, <fpage>129</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1177/1091581818821921</pub-id><pub-id pub-id-type="pmid">30663459</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Violi</surname><given-names>J.
                            P.</given-names></name><name><surname>Mitrovic</surname><given-names>S.
                                M.</given-names></name><name><surname>Colville</surname><given-names>A.</given-names></name><name><surname>Main</surname><given-names>B.
                                J.</given-names></name><name><surname>Rodgers</surname><given-names>K.
                                J.</given-names></name></person-group> (<year>2019</year>).
                        <article-title>Ecotoxicology and Environmental Safety Prevalence of
                        β-methylamino-L-alanine (BMAA) and its isomers in freshwater
                        cyanobacteria isolated from eastern Australia</article-title>.
                        <source/>Ecotoxicol. Environ. Saf.
                    <volume>172</volume>, <fpage>72</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2019.01.046</pub-id><pub-id pub-id-type="pmid">30682636</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakabayashi</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>S.</given-names></name><name><surname>Ohama</surname><given-names>E.</given-names></name><name><surname>Ikuta</surname><given-names>F.</given-names></name></person-group>
                        (<year>1988</year>). <article-title>Parkinson’s disease: the
                        presence of Lewy bodies in Auerbach’s and Meissner’s
                        plexuses</article-title>. <source/>Acta Neuropathol.
                    <volume>76</volume>, <fpage>217</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1007/bf00687767</pub-id><pub-id pub-id-type="pmid">2850698</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingate</surname><given-names>D.</given-names></name></person-group>
                        (<year>1999</year>). <article-title>Gastrointestinal dysfunction in
                        ALS</article-title>. <source/>Amyotroph. Lateral Scler. Other Motor Neuron
                        Disord.
                    <volume>1</volume>:<fpage>2</fpage>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>